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Abstract
The development of more sensitive and more reliable sensors aids medical ap-
plications in many fields as diseases detection or therapy progress. This thesis
threats the development of an optical biosensor based on electromagnetic modes
propagating at the interface between a finite one-dimensional photonic crystal
(1DPC) and a homogeneous external medium, also named Bloch Surface Waves
(BSW). BSW have emerged as an attractive approach for label-free sensing in
plasmon-like sensor configurations. Besides label-free operation, the large field
enhancement and the absence of quenching allow the use of BSW to excite flu-
orescent labels that are in proximity of the 1DPC surface. This approach was
adapted to the case of angularly resolved resonance detection, thus giving rise to
a combined label-free/labelled biosensor platform. BSW present many degrees of
design freedom that enable tuning of resonance properties. In order to obtain a
figure of merit for an optimization, I investigated the measurement uncertainty
depending on resonance width and depth with different numerical models. This
has led to a limit of detection that can assist the choice of the best design to
use. Two tumor biomarkers, such as vascular endothelial growth factor (VEGF)
and Angiopoietin-2 (Ang2), have been considered to be detected with the BSW
biosensing platform. For this purpose the specific antibodies for the two tumor
biomarkers were immobilized on the 1DPC biochip surface. The conclusive exper-
iments reported in this work demonstrated the successful detection of the VEGF
biomarker in complex matrices, such as cell culture supernatants and human
plasma samples. Moreover, the platform was used to determinate Ang2 concen-
tration in untreated human plasma samples using low volumes, 300 µL, and with
short turnaround times, 30 minutes. This is the first BSW based biosensor assay
for the determination of tumor biomarker in human plasma samples at clinically
relevant concentrations.
Abstract
Lo sviluppo di sensori sempre più affidabili e sensibili può favorire la ricerca
medica in campi come la diagnosi di malattie o il monitoraggio dell’efficacia
delle terapie. Questa tesi riporta lo sviluppo di un biosensore ottico basato su
modi elettromagnetici di superficie che si propagano all’interfaccia tra un cristallo
fotonico unidimensionale (1DPC) ed un mezzo esterno omogeneo, conosciuti
con il nome di onde di superficie di Bloch (BSW). Molta attenzione è stata data
alle BSW da quando sono state utilizzate per il rilevamento diretto (label-free)
di biomolecole con configurazioni simili a quelle dei sensori plasmonici. Oltre
alle configurazioni label-free, la grande amplificazione del campo elettrico sulla
superficie del 1DPC e l’assenza di quenching permettono di usare le BSW per
eccitare molecole fluorescenti che si trovino in prossimità dell’interfaccia. In
questo lavoro i due approcci, label-free e fluorescente, sono stati combinati su
un’unica piattaforma che permette il rilevamento con entrambi i modi di detec-
tion. Il design di un biosensore basato su BSW presenta molti gradi di libertà. Al
fine di ottenere una figura di merito per un’ottimizzazione, ho indagato alcuni
parametri chiave delle BSW con diversi modelli numerici. Questo ha portato
alla definizione di un limite di rilevamento teorico (LoD) che ha determinato la
scelta del miglior design da utilizzare. Due biomarcatori tumorali quali il fattore di
crescita vascolare endoteliale (VEGF) e l’Angiopoietina-2 (Ang2) sono stati scelti
per essere rilevati con la piattaforma. A questo scopo gli anticorpi specifici per
i due marcatori tumorali sono stati immobilizzati sulla superficie del 1DPC. Gli
esperimenti conclusivi riportati in questo lavoro hanno dimostrato con successo
la rilevazione del biomarker VEGF in matrici complesse. Inoltre, la piattaforma
è stata impiegata per rilevare concentrazioni di Ang2 in plasma umano usando
volumi ridotti, 300 µL, e con tempi di risposta brevi, 30 minuti. Quello riportato è
il primo saggio per la quantificazione di concentrazioni clinicamente rilevanti di
biomarker tumorali in plasma umano che utilizzi un biosensore basato su BSW.
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Introduction
" In the short stories Storie Naturali, Primo Levi tells of one of the many techno-
logical wonders put on the market by a mysterious American company: il Mimete,
The Mimer, this is the name of the machine that duplicates documents, but not as
a common copier. It does its job recreating on another paper the characters and
symbols printed on the first: the Mimer recreates in all respects the document,
the fibers and the imperfections of the paper, the lacerations, the "spots in a
duplication process in which in the exact position of each atom of the model is
fixed a similar atom extracted from its ink: carbon where it was carbon, nitrogen
where it was nitrogen, and so on...It was really a revolutionary technique: organic
synthesis at low temperature, the order from disorder, quickly and cheaply: the
dream of four generations of chemists" [Levi (1987)]. The operation of the Mimer
closely resembles the dream of the first supporters of nanotechnology: the chance
to grow in a controlled manner and with great efficiency nanoscale structures and
machines, assembling atom by atom molecular sized objects with well-defined
functions.
In the same year in which the Levi’s novels were sold in bookshops, the mouvie
Fatastic Voyage made its appearance in the cinemas. The movie proposed to the
audience a bold vision of nanotechnology applied to medicine: a team of doctors
were miniaturized in order to remove from the inside a dangerous blood clot in
the brain of a patient.
Probably, the situations described above belongs only to the realm of science
fiction. Still, nanotechnology is enhancing biomedical research tools, for example,
by providing new kinds of labels for experiments done to discover drugs or to
reveal which sets of genes are active in cells under various conditions. Researchers
are also exploiting nanoparticles as improved contrast agents for noninvasive
imaging and as drug-delivery vehicles. Nanotechnology devices, moreover, can
play an important part in diagnostic screens in order to detect in a fast and reliable
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way if any disease or cancer is developing in the patient.
This is precisely the leitmotiv of my doctoral thesis, contribute to the realization of
a new biosensor that uses what nanotechnology has to offer for cancer prevention.
The World Health Organization states that the number of new cases of cancer is
expected to rise from 14 million in 2012 to 22 within the next 2 decades [Stewart
and Wild (2014)]. Cancer is among the leading causes of morbidity and mortality
worldwide, with approximately 8.2 million cancer related deaths in 2012 [Fer-
lay et al. (2015)]. Metastases are the major cause of death from cancer [Mehlen
and Puisieux (2006)]. For many types of cancer, early and accurate detection
allows treatment before the metastatic process begins. Therefore, early diagnosis
plays a vital role for a successful therapy of the disease. Quantitative detection
of cancer biomarkers is a powerful tool to diagnose cancers in early stages [Pepe
et al. (2001)]. Furthermore, cancer biomarkers are used as noninvasive tool to
monitor the response to the treatment. Although enzyme-linked immunosorbent
assay (ELISA) is considered the preferred technique for measuring biomarkers’
concentration in plasma, conventional ELISA tests are time-consuming, require
highly specialized staff and specific laboratory equipment [Tighe et al. (2015)].
The development of a sensitive, compact and easy to use platform for real-time
detection of cancer biomarkers would represent a major breakthrough in both
clinical and research field.
Optical biosensors provide a valid alternative to ELISA for the detection of many
kinds of biomolecules including tumor biomarkers [Tan et al. (2008),Ulber et al.
(2003)]. Optical biosensing is based on two detection approaches, one making
use of fluorescent labels and the other label-free [?]. Both methods have their ad-
vantages and drawbacks. Label-free techniques, like Surface Plasmon Resonance
(SPR), are generally used to investigate in real-time the kinetics of surface-binding
events. These provide quantitative information on both the specific recognition
of a biomolecule and knowledge about the binding constants, such as the affin-
ity [Dey et al. (2012),Guo (2012),Karlsson et al. (1991),Liu et al. (2008),Piliarik
et al. (2007),Sikarwar et al. (2017),Ulber et al. (2003)]. While the latter is a unique
and valuable feature of the label-free detection method, sensitivities are usually
lower compared to the fluorescent counterpart [Huber et al. (1992),Mathias et al.
(2007)]. For this reason, optical schemes exploiting evanescent waves, which
feature strong field localization and intensity enhancement at the surface of inter-
est, have been put forth [Anopchenko et al. (2016),Cooper (2002),Descrovi et al.
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(2013),Fan et al. (2008),Fort and Grésillon (2008),Ligler and Taitt (2008),Pokhriyal
et al. (2010),Zhao et al. (2010)]. Among evanescent wave sensors those based on
Bloch surface waves (BSW) sustained by dielectric one dimensional photonic
crystals (1DPC) was proposed and demonstrated as valid alternative to SPR for
label-free optical biosensing [Konopsky et al. (2013),Paeder et al. (2011),Rivolo
et al. (2012),Rizzo et al. (2014a),Shinn and Robertson (2005),Sinibaldi et al. (2015)].
The direct comparison of the performance of BSW and SPR biosensors showed
that evanescent waves on all-dielectric structures can outperform their metallic
counterpart [Sinibaldi et al. (2012)]. Furthermore, BSW were used to enhance the
fluorescence emission from fluorescent molecules near 1DPC surfaces [Angelini
et al. (2014a),Angelini et al. (2013),Badugu et al. (2013),Descrovi et al. (2010),Ray
et al. (2015),Ricciardi et al. (2015)]. Although encouraging, all these experiments
were conducted with biomarkers spiked in simple matrices such as phosphate
buffered saline (PBS). In order to obtain clinically relevant results it is essential to
perform the biomarker detection in more complex matrices such as blood plasma
or other biological fluids.
In this thesis it is presented the detection of biomarkers in biological fluids by
means of a compact and multifunctional point-of-care platform. The biosensing
platform exploits BSW on disposable and low cost 1DPC biochips, whose unique
design allows both label-free and fluorescence detection. The first chapter deals
with a brief description of photonic crystals and BSW. It also illustrates the de-
sign and optimization of 1DPC for biosensing experiments. The second chapter
focuses on the 1DPC production and the optical setup used. Chapter three de-
scribes the surface functionalization protocols adopted to make the 1DPC surface
bio-compatible prior the bioassays. Chapter four will report on the biosensing
experiments detecting angiogenic biomarkers in real world complex matrices like
cell culture supernatant and human plasma samples.
"
Chapter 1
One dimensional photonic crystals
and Bloch surface wave
" In the last 20 years the development of new optical technologies has accelerated
significantly. These technologies generally aim at the development of low cost
optical systems designed for specific applications that have to be compact and
robust. The goal is to control the optical properties of materials that in turn will
control light. Fundamental components of these new optical systems are the
class of materials known as photonic crystals (PC). A PC is a material in which
an appropriate periodic refractive index variation is defined in one, two or three
dimensions in space (Fig. 1.1).
Fig. 1.1 Simple examples of one, two, and three dimensional photonic crystals. The different
colors represent materials with different dielectric constants. The defining feature of a photonic
crystal is the periodicity of dielectric material along one or more axes.
A crystal is a periodic arrangement of atoms or molecules. The pattern with
which the atoms or molecules are repeated in space is the crystal lattice. The
crystal presents a periodic potential to an electron propagating through it, and
5both the constituents of the crystal and the geometry of the lattice dictate the
conduction properties of the crystal. Importantly, however, the lattice can also
prohibit the propagation of certain waves. There may be gaps in the energy
band structure of the crystal, meaning that electrons are forbidden to propagate
with certain energies in certain directions. The optical analogue is the photonic
crystal, in which the atoms or molecules are replaced by macroscopic media with
differing dielectric constants, and the periodic potential is replaced by a periodic
dielectric function (or, equivalently, a periodic index of refraction). However, PC
are not a new idea; in nature many biological systems exploit a sub-micrometric
periodic structure of dielectric materials and Lord Rayleigh published one of the
first analyses of the optical properties of multilayer films in 1887 [Rayleigh (1888)].
But it is only in the 80’ that the PC concept was introduced together with that of
photonic bandgap structure (PGB) [Yablonovitch (1987)].
Many of the most remarkable effects in these structures are related with the
formation of forbidden gaps within the band structure. Indeed, if the dielectric
constants of the materials in the crystal are sufficiently different, and if the ab-
sorption of light by the materials is minimal, which is true for dielectric materials,
then the refractions and reflections of light from all of the various interfaces can
produce many of the same phenomena for photons (light modes) that the atomic
potential produces for electrons. The simplest possible photonic crystal, shown in
Fig. 1.1 on the left, consists of alternating layers of material with different dielectric
constants: a one dimensional photonic crystal (1DPC), practically a multilayer.
A multilayer made of an infinite number of planar layers of thickness d oriented
perpendicular to the direction z is considered (Fig. 1.2) [Novotny and Hecht (2012)].
The dielectric constant of the layers is assumed to alternate between the values
ε1 and ε2. The optical mode propagating inside the material is characterized by
the wavevector k=(kx , ky , kz). It is further assumed that both materials are non-
magnetic, i.e. µ1 = µ2 = 1, and lossless. Two kinds of modes can be distinguished,
TE modes, for which the electric field vector is always parallel to the boundaries
between adjacent layers, and TM modes, for which the magnetic field vector is
always parallel to the boundaries. Separation of variables leads to the following
equations for the complex field amplitudes:
T E : E(r)= E(z)e i (kx x+ky y))nx , (1.1)
T M : H(r)=H(z)e i (kx x+ky y))nx . (1.2)
6In each layer n, the solution for E(z) and H(z) is a superposition of a forward
and a backward propagating wave, i.e.
T E : En, j (z)= an, j e i kz j (z−nd)+bn, j e−i kz j (z−nd), (1.3)
T M : Hn, j (z)= an, j e i kz j (z−nd)+bn, j e−i kz j (z−nd). (1.4)
where an, j and bn, j , are constants that depend on the layer number n and the
medium ε j . The longitudinal wavenumber kz j is defined as
kz j =
√
ω2
c2
ε j −k2∥ , k∥ =
√
k2x +k2y , (1.5)
with k∥ being the parallel wavenumber. To find the constants an, j and bn, j the
boundary conditions at the interface are supplied z = zn = nd between the nth
and the (n + 1)th layer:
En,1(zn)= En+1,2(zn), (1.6)
d
d z
En,1(zn)= d
d z
En+1,2(zn), (1.7)
Hn,1(zn)=Hn+1,2(zn), (1.8)
1
ε1
d
d z
Hn,1(zn)= 1
ε2
d
d z
Hn+1,2(zn). (1.9)
Fig. 1.2 A one-dimensional photonic crystal made of an infinite number of planar layers of
thickness d.
Equation 1.7 is derived by expressing the transverse component of the mag-
netic field in terms of the electric field by using ∇× E = i ωµ0 H. Similarly, Equa-
7tion 1.9 follows from ∇× H = -i ωε0ε E. Inserting Equations 1.3 and 1.4 leads
to
an,1+bn,1 = an+1,2e−i kz2 d +bn+1,2e i kz2 d , (1.10)
an,1−bn,1 = pm
(
an+1,2e−i kz2 d −bn+1,2e i kz2 d
)
, (1.11)
where pm ∈ (pT E , pT M ) is a factor that depend on the polarization as
pT E =
kz2
kz1
(T E modes) , pT M =
kz2
kz1
ε1
ε2
(T M modes). (1.12)
For a given mode type there are two equations but four unknowns, i.e. an,1,
bn,1, an+1,2, and an+1,2. Thus, more equations are needed. Evaluating the bound-
ary conditions at the interface z = zn−1 = (n−1)d between the (n-1)th and nth
layers leads to
an−1,2+bn−1,2 = an,1e−i kz1 d +bn,1e i kz1 d , (1.13)
an−1,2−bn−1,2 = 1
pm
(
an,1e
−i kz1 d −bn,1e i kz1 d
)
, (1.14)
Although four equations for each mode type were derived, the number of
unknowns were increased by two, i.e. by including an−1,2 and bn−1,2. However,
these two can be expressed in terms of an+1,2 and bn+1,2 with the help of the
Floquet–Bloch theorem. This theorem states that if E is a field in a periodic
medium with periodicity 2d then it has to satisfy
E(z+2d)= e i kBl 2d E(z), (1.15)
where kBl is a wavevector, called the Bloch wavevector. A similar equation
holds for the magnetic field H(z). Application of the Floquet–Bloch theorem leads
to
an+1,2+bn+1,2e−2i kz2 [z−(n−1)d ] = e i kBl 2d
(
an−1,2+bn−1,2e−2i kz2 [z−(n−1)d ]
)
. (1.16)
Since this equation has to hold for any position z, it needs to be required that
an+1,2 = an−1,2e i kBl 2d , (1.17)
8bn+1,2 = bn−1,2e i kBl 2d , (1.18)
which reduces the number of unknowns from six to four and allows to solve the
homogeneous system of equations defined by Equations 1.10- 1.14. The system
of equations can be written in matrix form and the determinant must be zero in
order to guarantee a solution. The resulting characteristic equation turns out to
be
cos(2kBl d)= cos(kz1 d)cos(kz2 d)−
1
2
(
pm + 1
pm
)
si n(kz1 d)si n(kz2 d). (1.19)
Since cos(2kBl d) is always in the range [-1...1], solutions cannot exist when
the absolute value of the right-hand side is larger than unity. This absence of
solutions gives rise to the formation of bandgaps. For each Bloch wavevector
kBl one finds a dispersion relation ω(k ∥). If all possible dispersion relations are
plotted on the same graph one obtains a so called band diagram. An example
is shown in Fig. 1.3, where the shaded areas correspond to allowed bands for
which propagation through the crystal is possible. Notice that propagating modes
exist even if one of the longitudinal wavenumbers (kz j ) is imaginary. The Bloch
wavevector at the band edges is determined by kBl d = npi/2. For a given direction
of propagation characterized by k∥ one finds frequency regions for which propaga-
tion through the crystal is possible and frequency regions for which propagation
is inhibited. However, for a 1DPC there is no complete bandgap, i.e. there are no
frequencies for which propagation is inhibited in all directions. If a wave prop-
agating in vacuum is directed onto the photonic crystal, then only modes with
k∥ smaller than k =ω/c can be excited. The vacuum light-lines are indicated in
Fig. 1.3 and one can find complete frequency bandgaps inside the region k∥ < k.
The band gap in a dielectric truncated 1DPC can be exploited to obtain
guiding of a surface mode, thus giving rise to surface sensitive evanescent field
sensors [Konopsky et al. (2013)]. These surface modes are called Bloch Sur-
face Waves (BSW) and can be excited by prism coupling in the well known
Kretschmann–Raether configuration. The following paragraphs address the opti-
mization of a BSW optical sensor based on a periodic 1DPC.
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Fig. 1.3 The band diagram for a 1DPC photonic crystal. The shaded areas are the allowed bands.
The diagram represents both TE and TM modes.
1.1 Optimization and design
Under total internal reflection (TIR) conditions, BSW may be revealed by a very
narrow dip in the angular reflectance spectrum, whose angular position depends
on surface perturbations and is used, for example, as a probe of molecular binding
events at the 1DPC surface. Here, a semi-analytical resonance model is applied
to discuss the effect of the detection noise on the resonance shift determination
for angularly resolved reflection analysis. Combining the results with the values
obtained for a figure of merit (FoM) of such sensors yields the limit of detection
(LoD), which is governed by the resonance properties as well as by its sampling.
Besides the choice of the detector, such sampling depends also on the (angular)
range to be detected. Moreover, both quantities, LoD and FoM, are simulated for
SPR and are used for a sample optimization of a low loss dielectric thin film stack
sustaining BSW.
Part of this section have been published in Rizzo et al. (2014a), all the calcula-
tions reported were carried out by means of self-written software that is based
upon a transfer matrix formalism (TMM). Using this tool the angularly resolved,
monochromatic reflectivity of the thin film system is simulated in the plane wave
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approximation when the sensor stack is illuminated from the (glass) substrate.
The interface between substrate back side and air is neglected. The numerical
procedure is readily illustrated in the inset of Fig. 1.4. First, the angularly resolved
reflectivity is calculated for the stack covered with water like medium of nA =
1.33 refractive index (curve 1 in Fig. 1.4(A)). From this curve the depth D and the
full with at half depth W are determined. Second, a 10 nm thick organic layer
(refractive index nor g = 1.45) is added to calculate curve 2 in Fig. 1.4(A). The sen-
sitivity S [deg/nm] is derived from the minima positions of curves 1 & 2. Third,
the maximum signal is assumed to be detected with 10 nm thick organic layer
and an increased solution refractive index nA = 1.36 thus yielding resonance 3 as
shown in Fig. 1.4(A). The angular range included between the upper limit of the
half depth of curve 3 and the lower limit of the half depth of curve 1 is used as an
estimation of the angular range A to be detected. These assumptions consider the
standard label-free operation range only.
Fig. 1.4 Scheme of angular resonance detection by means of a Fourier imaging approach utilizing
a lens with focal length f. The angular range A is discretized with N detector pixels that transform
the angular width W of the resonance into a width w in terms of detector pixels. Inset A illustrates
that discretization needs to resolve small signal shifts (curves 1 and 2) but is practically limited by
the free measurement range (curve 3). Inset B illustrates the general stack that yields signal shifts
due to organic layer adsorption as well as changes of analyte refractive index nA .
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1.2 Basic experimental scheme and noise estimation
A sketch of the experimental scheme used to measure angularly resolved reflectiv-
ity is shown in Fig. 1.4. The optical functions of half ball and Fourier lenses will
be combined within the chip substrate to create small systems with disposable
chips that will be shown later. A monochromatic analysis is considered here in
order to leave material dispersion effects out of the discussion. Then the angular
spectrum of reflected light intensity is detected by means of an array detector with
N pixels. The surface mode resonance observed in the reflected angular spectrum
is characterized by a depth D and an angular width W (capital letter W) given in
degrees. Sampling by the detector with limited dynamic range yields a discretized
curve exhibiting a width w (lower case letter ’w’) measured in detector pixels. The
latter width is assigned the unit pix to distinguish w and W.
The sensitivity Sbulk is usually defined as the shift of the resonance position
(degrees) due to bulk refractive index changes (RIU). Such value can be easily
determined experimentally when using liquids with different refractive indices.
In the current frame this definition is misleading. Dielectric systems allow for
positioning the resonance at any (angular) position. As will be exemplified later,
the sensitivity also depends on the resonance position which governs the penetra-
tion depth of the evanescent field into the (aqueous) analyte solution. Defining
the sensitivity over the bulk refractive index of this analyte solution will yield
maximum sensitivity at the angle of total internal reflection because then the
evanescent field is infinitely extended into this medium. Therefore, sensitivity
Sl ayer is defined as the signal given in degrees relative to an organic layer thickness
change given in nanometer, while assuming a refractive index of nor g = 1.45 for
such layer. In order to evaluate the sensor performance the effect of the resonance
width and depth on the noise of the sensor output (resonance shift) needs be
quantified. A simplified square polynomial model that mimics fitting the res-
onance in the region of minimum reflectivity is assumed for this analysis and
sketched in Fig. 1.5(A). It could directly represent an experiment that saturates the
detector outside the angular range around minimum reflectivity. The approach
y(x)= a2·x2+a1·x+a0 ⇒ xmi n =− a1
2 ·a2
⇒∆xmi n =
∣∣∣∣ ∆a12 ·a2
∣∣∣∣+∣∣∣∣∆a2a2 · xmi n
∣∣∣∣ . (1.20)
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is used to derive xmi n because of its linearity with respect to all fit parameters.
The error for the minimum position determination depends on xmi n itself because
the uncertainty on the two parameters a1 and a2 is correlated and not indepen-
dent. However, Eq. 1.20 can be applied in the case xmi n ∼ 0 in order to estimate
the noise effect. According to the illustration in Fig. 1.5(A) the depth D and width
w of the resonance completely define a quadratic polynomial for a given dynamic
range of the detector. So the parameters ai and thus xmi n are known exactly, and
the parameter errors ∆ai are determined numerically from the diagonal elements
of the covariance matrix C according to σ2(ai ) = Ci i [Ziegel et al. (1987)]. This
allows one to model the measurement noise by assuming an intensity uncertainty
σi associated to each pixel’s intensity value yi . The detection shot noise σ2 ∼ yi
is considered, assuming it to be 0.6% of light intensity as previously suggested
[Piliarik and Homola (2009)], and the digitization error, assuming one count of
the analog-to-digital converter.
In the case of extremely narrow resonances one has also to consider effects due to
limited sampling (discretization). This is illustrated in Fig. 1.5(B) for an arbitrary
continuous function f(x). The intensity detected by each pixel corresponds to a
spatial integration and results in the error
yi = 1
∆x
·
∫ xi+∆x/2
xi−∆x/2
f (x) ·x →∆yi = yi − f (xi )=− (∆x)
2
24
f "(xi )−O
(
f (4); (∆x)4
)
.
(1.21)
This discretization error is proportional to the second derivative of the func-
tion under consideration. It is worth to point out explicitly that in the square
polynomial approximation a constant intensity offset (∼ a2) is added to the data.
So it cannot be considered noise and might be dropped for the present analysis.
But, similar effects are introduced by mechanical vibrations of the setup that will
yield higher order errors when fitting real data. Therefore the simulation results
will be shown with and without inclusion of the discretization noise effect. The
total contribution of shot noise, digitization error and discretization error are then
given by the lowest order of approximation from Eq. 1.21 and yield a total intensity
uncertainty in each pixel
σ2i = 1+
6
1000
· yi +
(a2
12
)2
. (1.22)
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Fig. 1.5 (A) Simplified model of resonance analysis using a quadratic polynomial to mimic the
resonance sampled by a 12 bit dynamic range detector. (B) Discretizing a function by spatially
extended pixels corresponds to a spatial integration of the distribution and yields discretized
intensity values yi (xi ) that differ from the ideal distribution f (xi ) by an amount yi .
Calculating the result of Eq. 1.20 when assuming the noise according to Eq. 1.22
yields the results shown in Fig. 1.6 In order to cross check such error estimation an
additional numerical experiment has been performed by adding numerical noise
to a Lorentzian function of width w and depth D = 0.7. The standard deviation of
the minimum position is deduced from fitting 1’000 different noise representa-
tions. The points shown in Fig. 1.6(B) almost perfectly match the results of the
square polynomial model for sufficient resonance widths.
Fig. 1.6 (A) Error of minimum position determination with respect to resonance depth for differ-
ent widths of the resonance; the black line illustrates a 1/D behavior. (B) Minimum position error
vs. resonance width for different depths of the resonance; the black line depicts the asymptotic
behavior. The dots illustrate uncertainties obtained from fitting Lorentzian curves of width w with
added numerical noise. All simulations assume a detector with 12 bit dynamic range; the solid and
the dashed curves give the error without or with inclusion of the discretization error, respectively.
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The results obtained by such numerical calculations can be summarized by
the following three major points:
1. According to Fig. 1.6(A) the accuracy of minimum determination is well
proportional to the inverse depth (∼1/D) of the resonance. Deviations occur
for very deep resonances (D>0.7) due to the fact that low intensities near the
minimum suffer from shot noise less. This law corresponds well to previous
findings [Piliarik and Homola (2009)].
2. The effect of the width onto the noise is well approximated by a x1/2 law
in the asymptotic case of large resonance widths. Such result confirms the
previous findings [?,Rizzo et al. (2014b)]. Enormous deviations appear for
bad sampling in the w<30 pix range when assuming the discretization error
to be noise. As its contribution is deterministic according to Eq. 1.6 this
assumption is debatable, and both models yield different suggestions for
optimum resonance width. But it reflects the fact that fitting the intensity
distribution of very narrow resonances might not be the method of choice
anymore, and resonance width shall be ensured to exceed a value around 10
pix. This result underlines that strongly decreasing resonance width requires
special attention in order to maintain proper sampling of the distribution.
3. Aside from such very narrow resonances the diagrams in Fig. 1.11 enable
one to extract an upper limit for the uncertainty of minimum determination
according to
∆xmi n ≤α
p
w/D. (1.23)
The noise decreases when increasing the dynamic range of the detector
(data not shown). As an example, with the assumptions outlined above
and the unit pix for the number of detector pixels, α12bi t = 6 ·10−4
√
pi x
and α8bi t = 2.8 · 10−3
√
pi x were obtained as factor of proportionality in
Eq. 1.23 when considering the noise levels obtained for 12 and 8 bit dynamic
range detection, respectively. This can be compared to previously reported
experimental data [Rizzo et al. (2014b)],where for a resonance with D = 0.15
and w = 32.4 pix experimentally was obtained ∆xexp = 0.12 pix for a 8 bit
detection. This is almost exactly the prediction∆xexp = 0.11 pix of the above
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model. Therefore Eq. 1.23 can be applied to the biosensors performance
estimation carried out below.
4. The diagram in Fig. 1.6(B) reveals a lower limit that depends on the detector
dynamic range and the discretization noise only. For the case of 12 bit
dynamic range detection the accuracy limit is in the 10−3÷10−2 pix range,
depending on the magnitude of the discretization noise.
1.3 Figure of merit and limit of detection
A FoM has been defined elsewhere [Sinibaldi et al. (2012)] in order to compare the
performance of different sensor approaches. It relates the depth D and width W
of the resonance to the sensitivity S according to
FoM =D · S
W
. (1.24)
Such FoM has been shown analytically to be maximized for intensity measur-
ing systems without spectral or angular resolution [Sinibaldi et al. (2013)]. Using
the sensitivity S and the sensor output noiseσS suggests using another assessment
criterion referred to the LoD [Piliarik and Homola (2009)] according toLoD =σS/S.
Note, that the choice of S = Sbulk or S = Sl ayer determines the unit of the LoD, so
it applies to both kinds of sensitivities. With the results of the previous section it
can be obtained
LoD ≤α ·
p
w
D ·S . (1.25)
According to Fig. 1.4, where the angular range A is sampled by N pix, the
detector’s pixel and angular scales are connected by σ[deg] = σ[pi x] · A/N and
w =W ·N /A accordingly. Applying both conversions and combining them with
Eq. 1.25 yields
LoD ≤α ·
p
W
D ·S ·
√
A
N
=α · 1
FoM ·pw . (1.26)
that needs to be minimized for sensor optimization. Due to the fact that the
angular sampling is determined by the angular range analyzed by the detector, the
LoD in Eq. 1.26 also contains he angular range A of observation, which needs to
consider the free measurement range as well as practical tolerances of the system.
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In the limiting case, when the detection system samples exactly the resonance
width, one obtains the minimum LoD|A=W ∼α /
(
FoM ·pN). Combining it with
the fact that FoM has been shown to apply to intensity only experiments strictly
[Sinibaldi et al. (2013)], the sensor performance measured by the FoM shall be
used in the case of a small angular detection range A ∼W . Whenever a larger
range needs to be detected, e.g. in case of parallel angularly resolved measure-
ment [Danz et al. (2011),Chinowsky et al. (2007),Naimushin et al. (2002)], if the
free measurement range including tolerances needs to be considered, or if flu-
orescence collection is desired as well [Sinibaldi et al. (2014)], the optimization
should minimize the LoD that also considers the resonance sampling. Thus, opti-
mum sensor performance can only be achieved with good FoM in combination
with a sufficient sampling of the resonance. In the following section the different
meanings of the LoD and FoM as performance measures will be illustrated by
discussing different types of plasmon like sensors.
1.4 Numerical evaluation
1.4.1 Surface plasmon resonance
First, surface plasmon sensing will be discussed as a reference. The thickness of
the metal layer is the only free parameter in the ’stack design’ once the metal has
been chosen. So different gold layer thicknesses on a glass substrate made of nBK7
are assumed to be used for sensing. The optical constants of gold are taken from
[Palik (1998)]. Calculation results are summarized in Fig. 1.7 for convenience. Both,
the FoM obtained according to Eq. (5) and the LoD according to Eq. 1.26 exhibit
local optima in the 800..850 nm spectral range when utilizing 45..55 nm gold layer
thicknesses. This implies to preferably use this wavelength range for sensing
issues as being done currently [Danz et al. (2011),Remy-Martin et al. (2012)]. With
the assumptions used here the LoD of such sensors should reach the picometer
range. This result needs to be cross checked with previous findings. The present
calculation yields a surface sensitivity of S ∼ 0.05deg/nm that corresponds to a
bulk refractive index sensitivity ofS ∼ 100deg/RIU . These data enable to convert
∆dmi n ∼ 0.8pm into ∆nmi n ∼ 3 ·10−7RIU, which agrees very well with previous
experimental findings [?,Piliarik et al. (2009)]. So the noise levels applied to the
LoD simulation yield a valid order of magnitude approximation.
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Fig. 1.7 Calculation results obtained for sensitivity figure of merit FoM (A) as well as limit of
detection LoD (B) vs. wavelength (650 nm <λ < 1’000 nm) for the case of 45 nm (dashed red), 50
nm (solid black) and 55 nm (dashdot blue) thick gold layers. LoD has been calculated assuming
the value N = 1’000 pix.
1.4.2 Bloch surface waves
As pointed out in the introduction the resonance width can be dramatically de-
creased when working with low loss dielectric stacks supporting Bloch surface
waves. Now more parameters can be accessed to tailor the sensor’s performance
and their range of variation explored. Besides the wavelength of operation the
choice of two materials, their thicknesses, and the number of periods need to be
considered. In order not make confusion with a too general and possibly heavy
description, it is sufficient to focus the attention on an exemplary case to put into
evidence the potential of BSW for sensing applications and develop a strategy to
design an optimized 1DPC.
As case of study the following structure is discusses at the wavelength λ = 670
nm: substrate |L|(HL)Np | water, where Np is the number of the periods that will
vary between 4 and 6. The materials Ta2O5 (nH = 2.106 + 3.5 ·10−5i ) and SiO2 (nL
= 1.474 + 6 ·10−6i ) are being used as high (H) and low (L) refractive index layers,
respectively. Comparable stacks [Munzert et al. (2003)] have been recently applied
for other BSW sensors [Sinibaldi et al. (2013),Sinibaldi et al. (2012),Sinibaldi et al.
(2014)]. The substrate index nS = 1.514 is chosen similar to the SPR case at the
corresponding wavelength. Fixing these prerequisites leaves the number of peri-
ods Np and the two thicknesses of the high (dH ) and the low (dL) refractive layers
open for optimization. The optimization procedure developed for the present
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case can be extended to stacks based on different materials, different spectral
ranges and also to aperiodic stacks.
At first the optimization will focus on maximum sensitivity because this value
determines the resonance shift that can be observed. The maps of the calculated
layer (Sl ayer ) and bulk (Sbulk ) sensitivities, obtained by scanning dL and dH with
a 10 nm and 5 nm step size, respectively, are shown in Fig. 1.8 for three different
values of Np . Regions without resonance appear for very thin stacks, i.e., in the
lower left corner of the diagrams in Fig. 1.8 (shown in black). This is caused by
the fact that the BSW at the given λ is below its cut-off. Two interesting results
can be derived from this analysis. First, the influence of the number of periods
Np on the BSW sensitivity is negligible, that is to say, the sensitivity variation with
the number of periods is below 1.5% only for all points in the graph. Second,
optima of Sl ayer appear in a narrow, nearly line shaped region near the BSW cut-
off. In such region, the optimum thicknesses of high and low index materials
are surprisingly correlated by the linear law dL = - dH + C, with C = 452.5 nm
for the stack design considered here and operating at the given λ, as shown in
Fig. 1.9(A). Fig. 1.9(B) illustrates the sensitivity along such a line: the mean value is
0.02 °/nm and the extrema differ by 0.6% only, thus proving that along such a line
a similar maximum can be found for all values of Np . In contrast, the bulk index
sensitivity Sbulk is maximized at the TIR edge, where the evanescent fields exhibit
maximum penetration into the aqueous analyte medium. Fig. 1.8 illustrates that
bulk sensitivity is no proper target for BSW biosensor optimization.
The resonance position and the angular range according to Fig. 1.4(A) are
shown in Fig. 1.10 for Np = 5 only. Other Np values yield similar maps with a
change of 0.01% for the resonance angle (θBSW ) and 2% for the angular range (A)
only. A monotonic behavior is observed when increasing the layers’ thickness;
the resonance position shifts towards larger angles and the angular range towards
smaller values. Interestingly, the Sl ayer optimized stacks exhibit almost the same
resonance angular position, i.e., maximum Sl ayer is achieved at a fixed propaga-
tion constant of the surface wave (dashed line in Fig. 1.10(A)). The angular range
has been determined for a 10 nm organic layer thickness increase only, therefore
it is governed by bulk index effects, as confirmed by Fig. 1.10(B) that qualitatively
resembles the Sbulk map shown in Fig. 1.8.
Once discussed the sensitivity, the dependency of the remaining parameters
contributing to the LoD, as defined by the Eq. 1.26, on the layers thickness needs
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Fig. 1.8 Sensitivity with regard to thin film binding Sl ayer (top row) and with regard to bulk index
changes Sbulk (bottom row) for the dielectric BSW systems subs |L|(HL)Np |water with different
number of periods. Sbulk is based on an external refractive index change of 0.01 starting from nA
= 1.33.
to be analyzed in order to optimize the performance of the BSW sensor. Especially
the resonance depth D and width W are highly influenced by the number of
periods, because this modulates the radiative losses into the substrate [Sinibaldi
et al. (2013)]. This is confirmed by the results shown in Fig. 1.11. For large Np
= 5,6 the smallest W is obtained close to the TIR edge (boundary of the dark
region), whereas for Np = 4 the resonance width seems to suggest an optimum
high index layer thickness in the range dH = 90..100 nm. Generally, the W values
span over two orders of magnitude for the simulated structures and decrease
when increasing Np . The region where the maximum D is obtained shifts towards
smaller thicknesses of the low index layer as the number of periods increases,
following a sort of parabolic shape with the high refractive index layer thickness.
In general, the number of periods should be utilized to adapt the system onto
changes of the material losses. Increasing such material losses requires decreasing
the number of periods, because this increases radiation losses. Such case might
be desired in order to simplify the stack or to increase resonance width and is
similar to the plasmon case [Professor Dr. Heinz Raether (1988)].
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Fig. 1.9 (A) Extrapolated pairs dL = f (dH ) from Fig. 1.8 with optimum sensitivity Sl ayer . The
linear law dL =−dH +452.5 nm that correlates the two thicknesses is unequivocally. Along this
line the sensitivity (B) varies by 0.6% only and has a mean value of 0.020 °/nm.
Fig. 1.10 Resonance position (A) and angular range (B) for the BSW stack subs |L|(HL)5 | water
determined according to Fig. 1.4(A). The white dashed line indicates Sl ayer optimized stacks
according to Fig. 1.9(A).
Combining all resonance features enables one to compile FoM and LoD maps
as shown in Fig. 1.12. Tuning the number of periods in the stack allows one to gen-
erate a large region (Np =5) with minimum LoD values in the range LoDmi n>0.04
pm. For the case Np = 6 small regions with comparable low values are found.
The most important contribution to the formation of such extended range of
well suited stacks with Np = 5 is the fact that sensitivity S and resonance depth D
are maximized in the same region of the map. Alternatively, this effect could be
achieved by adjusting the absorption losses of the stack materials. But this will
increase the resonance width, which in turn results in an increased LoD.
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Fig. 1.11 Resonance full width half maximum W (first row) and depth D (second row) for the
BSW stacks subs |L|(HL)Np | water with Np = 4,5,6 (columns).
1.5 Considerations about the sensitivity
The interesting resonance properties obtained for the exemplary stack discussed
here require some further discussion. First, the sensitivity has been found to be
independent of the number of periods. This can be explained by the reflection
of the surface wave at the substrate side dielectric stack: for the angles under
consideration, the phase of such reflection is almost independent of the number
of periods. Because of the large index difference of nL and nH , deviations occur
for lesser numbers of periods only. Second, the surface sensitivity SLayer exhibits
a clear optimum near the TIR edge with the optimum angle being well separated
from this edge. Such effect is associated with the TIR at the interface to the analyte
medium and will be discussed in detail elsewhere. The optimum performance for
the exemplary BSW sensor achieved here reaches FoMmax ∼24 nm−1 that is more
than two orders of magnitude above that of SPR. But, minimum LoDmi n ∼0.04
pm is ’only’ a factor 20 below that of SPR. This illustrates that the superior finesse
of BSW sensors, that could be associated with the ratio S/W, can be partially
translated into LoD reduction only. As the sensitivity governs the angular range to
be detected, it simultaneously limits the sampling of the angular distribution and
increases the noise of resonance position determination. In our calculations a N
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Fig. 1.12 Simulated FoM (top row) and LoD (bottom row) assuming 1’000 pix detector for
different number of periods (columns).
= 1’000 pix detector has been assumed, while W∼0.001° and A∼1° for optimized
stacks has been obtained. This illustrates that sampling will tremendously affect
reflection intensity based resonance analysis. With regard to Fig. 1.6(B) such
superior performance requires one to improve the detector sampling along with
the mechanical stability of set-up. Note, that even varying the number of periods
in an optimized stack (dL ∼360 nm, dH ∼95 nm) from Np = 5 to Np = 4 or 6
will reduce the LoD and FoM but still yield a performance improvement when
comparing to SPR. Furthermore, the large region of layer thicknesses for optimized
stacks in the Np = 5 indicate that limited fabrication accuracy will not constrain
the sensor performance.
1.6 Coupled fluorescence
It is well known that the fluorescence generated by an emitter can be strongly
modified by the photonic environment. In analogy with the density of electronic
states (DOS), the Local Density of electromagnetic States (LDOS) stands for the
available electromagnetic modes in which photons can be radiated from a specific
location. The emission from a dipole-like source in free-space results in a spherical
isotropic radiation pattern because of the infinite eingemodes of the vacuum.
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However, when the emitter is in close proximity to a 1DPC, in which the dielectric
constant varies spatially on the length scale of the same order of the emitted
wavelength, the decay properties of the emitter are modified according to the
photonic band structure and so is the radiation pattern. This effect will be used
to provide a tandem detection mode, i.e. label-free/fluroescence, for a BSW
biosensing platform. Moreover, The emitter can be excited by a BSW on the
interface between a truncated 1DPC and an external medium. Due to the fact
that BSW works in TIR conditions, only molecules near the surface (within the
exponentially decreasing intensity distribution of the evanescent field in the
external medium) will be excited (Fig. 1.13).
Fig. 1.13 Illustration of the basic effects arising when exciting and observing fluorescence on top
of a BSW supporting thin film stack. Excitation is shown on the left and emission on the right side.
Fluorescence excitation exploits the same effect of field enhancement that is
utilized for label-free sensing. Then, maximum interaction of the emitter on the
surface with the light wave impinging from the substrate is reached. Once excited,
the molecules emit the energy into all electromagnetic modes of the system. In
this process, modes with increased energy density at the emitter position are
preferably excited. In result, the field enhancement of the BSW excitation forces
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the energy to be emitted into the dispersion of the BSW stack (Fig. 1.13).
BSW coupled emission has been studied using the tool Radiating Slabs (Fraun-
hofer IOF) and that has been applied successfully in a quantitative manner to
emission problems in stratified media previously. Parameters like number of
layers and resonance angles have been varied to optimize the fluorescence de-
tection. In result, a few summaries and/or conclusions can be drawn from these
optimizations: increasing the number of layers (periods) in a BSW stack does not
improve fluorescence detection efficiency. But it decreases the emission reso-
nance width. The reason for such results seems be twofold: first, extinction in
the layers causes elevated losses when increasing the total thickness. Second,
increasing the stack thickness introduces (more) guided modes that can drain the
energy of the excited emitting molecules. Optimizing algorithm tries to achieve
TE and TM resonant emission at similar angles close to the TIR edge, because the
sum of both polarizations has been set as figure of merit. All of the results are
local (numerical) optima. There is no proof that such results are global optima.
Therefore, any later label-free based stack analysis will have to explicitly review
the effect of the stack onto the fluorescence.
"
Chapter 2
Production of 1DPC and optical
setup
" The thin film stack has to fulfill several tasks in order to achieve appropriate
operations of the sensor system: it needs to exhibit correct resonance properties
(according to the design) as well as to provide convenient surface properties for
later biochemical functionalization and immobilization. Moreover, the fabrica-
tion method has to be reliable in terms of a subsequent series production with
very low tolerances and with a high number of substrates that can be coated
in a single deposition run. For this reason although two deposition techniques
were, i.e. plasma enhanced chemical vapor deposition (PECVD) and plasma-ion
assisted vacuum evaporation (PIAD), only the 1DPC coated with the latter method
were used for the biosensing experiments. Furthermore, PIAD has the possibility
to deposit coatings with an adjustable densification and stoichiometry at low
substrate temperature which make the technique suitable for the deposition of
the 1DPC on polymeric substrates.
2.1 Plasma Enhanced Chemical Vapor Deposition
Silicon-based alloys have been studied in order to check the feasibility of their use
in the fabrication of 1DPC sustaining BSW. Silicon-based amorphous thin-film
alloys are materials of considerable interest and have been studied extensively by
the scientific community for a wide range of applications, including microelec-
tronics [Wu et al. (2014),Pomorski et al. (2014),Kim et al. (2003)], photovoltaics
[Shi et al. (2013),Wan et al. (2013)], tribology [Jiang et al. (2014)], biomedicine
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[Mandracci et al. (2008)] and photonics [Luo et al. (2013),Lin et al. (2015)]. An
important characteristic of these materials, which is related to their amorphous
structure, is the possibility of finely adjusting the relative amount of the elements
that compose the alloys, thus allowing their physical and chemical properties
to be tuned. These features can be exploited when these materials are grown
by means of plasma enhanced chemical vapor deposition (PECVD), since this
technique allows the element incorporation to be controlled by changing the
percentage of the feedstock gases in the reactor [Mandracci and Ricciardi (2007)]
with a thickness control at the nanometric scale [Giorgis et al. (1999)]. The PECVD
is a modification of the CVD process, in which a plasma is used as a source of
energy in order to obtain the dissociation of the reactive gases at temperatures at
which they would not dissociate thermally. A plasma can be described as a gas
in which a part of the atoms (or molecules) have been ionized. There are three
constituents: neutral atoms or molecules (depending of the type of gas), ions and
electrons. The ratio between the number of ionized particles and the neutral ones
is called degree of ionization. The degree of ionization of the plasmas used for
PECVD can vary in the range 10−6÷10−4.
The apparatus used is located in a professional clean room ,class 1000 and in
Fig. 2.1 a scheme of the whole system is shown. It consists of two deposition cham-
bers: the first used for Electron-Cyclotron-PECVD processing and the second for
the RF-PECVD processing. The last is used for the deposition of thin films and
multilayers. Each one of the two deposition chambers is separated from the load-
lock chamber by a gate valve. The two chambers are always kept under vacuum
pumping condition; the introduction of the substrates is achieved through the
load-lock chamber with the following scheme:
1. the substrate is introduced in the load-lock chamber;
2. the load-lock chamber is pumped down to a pressure lower then 10−4Torr;
3. the gate valve between the load-lock and the deposition chamber is opened;
4. the substrate is moved from the load-lock chamber to the deposition cham-
ber by a vacuum tight transfer system;
5. the gate valve is closed.
This procedure allows to avoid the contact of the deposition chamber with
the open air, reducing the risk of contamination of the grown film. The reverse
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procedure is used for the extraction of the grown films from the deposition cham-
ber. The use of the load-lock system allows also the transfer of a sample from one
chamber to the other without exposing the film surface to air.
The RF-PECVD reactor is a stainless steel cylinder with a diameter of 250 mm
and a height of 285 mm. The chamber is provided with:
• an ionization gauge for themeasurement of the ultimate pressure before
processing (which is usually in the range 10−8÷10−7Torr);
• a capacitance manometer gauge head, a throttle valve and relative auto-
matic pressure controller for the regulation and measurement of the gas
pressure during the deposition process;
• a gas manifold with mass flow controllers and associated control units, for
the control of the flow of the reactive gases: SiH4, CH4, NH3, CO2 and H2.
The substrate is introduced in the chamber by means of two stainless steel rails
and is faced downwards to avoid accumulation of dust particles on the surface.
The process gases are introduced by a gas diffusion ring and are evacuated by the
pumping system. The pumping system consists of a turbomolecular pump and a
mechanical pump in sequence. The mechanical pump has a pumping speed of
25 m3/h and allows a minimum pressure of about 10−4Torr; the turbomolecular
pump has a pumping speed of 300 l/s and allows a minimum pressure of about
10−9Torr. All pumps are purged by nitrogen to protect some of their most sensitive
parts and to avoid possible accumulation of toxic or explosive components when
reactive gases are used. The heating is performed by irradiation from a resistor
located at the top part of the deposition chamber, at a distance of 20 mm from
the substrate. The control of the temperature is performed by a temperature
controller , which is connected to a type K thermocouple, the point of which is
located in a hole in the center of the heater. The maximum temperature that can
be achieved is 500°C.
2.2 Growth of amorphous silicon-based thin films
The silicon nitrides and the silicon oxycarbides were grown by means of the
PECVD apparatus described before at a temperature of 493 K, using a fixed total
mass flow rate of 7.4·10−5mol s−1(100 sccm). The other deposition parameters:
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Fig. 2.1 Double-chamber growth apparatus with details concerning with the PECVD reactor.
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radio frequency power density, total pressure and relative fractions of the reactive
gases are reported in Table 2.1. Single layers were grown on 4 inches silicon wafers
to allow optical characterization by means of UV–vis spectroscopy in reflective
mode. A small area in the center of each wafer was masked to leave an uncoated
region, in order to allow thickness measurements to be made. These results have
been published in Mandracci et al. (2016).
VIS-NIR reflectance spectra were obtained using an Agilent Cary 5000 (Agi-
lent California, USA) UV–visible–NIR spectrophotometer equipped with a 12.5°
reflectance unit, in the 400–1000 nm range. The film thickness was estimated
by means of a mechanical profilometer (Tencor P10-A) by measuring the height
of the step between the uncoated region and film surface. The deposition rate
of each material was then calculated, as the ratio between film thickness and
deposition time, as reported in Table 2.1. The dispersion of the refractive indexes
was obtained from the interferometric pattern of the reflectance spectra and the
measured thickness of the amorphous silicon based thin film.
Table 2.1 Growth parameters applied for the synthesis of the a-SiNx :H and a-SiOx Cy :H thin-
films. Uncertainties were estimated from the instrumental uncertainties given by the equipment
producers.
a-SiNx :H (high n) a-SiNx :H (low n) a-SiOx Cy :H
Power density [mW cm−2] 40±1 40±1 60±1
Total pressure [Pa] 80±1 80±1 73±1
[SiO4]% 20±0.2 4±0.04 1±0.01
[NH3]% 80±0.8 96±1 0
[CH4]% 0 0 29±0.3
[CO2]% 0 0 70±0.7
Growth rate[nm min−1] 19±1 18±1 5.2±0.1
Fig. 2.2 shows that the refractive index of a-SiNx :H grown with 96% of NH3
in the SiH4+NH3 gas mixture is markedly lower than in the silicon-nitride layer
grown with 80% of NH3 (n=1.77 vs. n=2.04 at 1000 nm). This is in agreement
with several other experimental findings [Giorgis et al. (1997)] and can be justified
considering the higher N incorporation in the amorphous network caused by the
by increase of the nitrogen precursor flux in the reactor chamber. The decrease in
the refractive index for the samples obtained by increasing the ammonia fraction
in the growth reactor can, in fact, be ascribed to the replacement of Si-Si bonds
(in Si-rich alloys) with strong Si-N and/or Si-H bonds in the amorphous silicon
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network [Robertson (1991)]. In addition, the refractive index obtained with 96% of
NH3 in the gas feedstock is typical of anamorphous silicon nitride thin film that
approaches the stoichiometry (i.e. a-SiN1.33:H). It is lower than the typical value
found for stoichiometric silicon-nitride grown by means of thermal Low Pressure
CVD (n∼2 in the low absorption energy range), because of the hydrogenation of
the PECVD alloys.
Fig. 2.2 Refractive index dispersion of a-SiNx :H and a-SiOx Cy :H thin films.
The refractive index is further reduced for the silicon-oxycarbide thin film,
where n=1.52 at 1000 nm is measured. Such a low value is due to the excess oxygen
incorporated in the SiC matrix [Miyazaki (2008)], which increases the degree of
freedom for the design of dielectric multilayers with high optical contrast.
2.3 Mulitalyers based on amorphous silicon alloys
1DPC based on binary and ternary silicon-based alloys were fabricated and char-
acterized at Politecnico di Torino. The optical features of the planar dielectric
multilayers based on the discussed amorphous silicon-based alloys are presented
hereafter. a-SiNx :H and a-SiOxCy :H multilayers were grown on thin glass wafers
of 150 µm thickness. The RF discharge was interrupted for 10 s and the deposi-
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tion chamber evacuated at each hetero-interface of the stratified structures. The
thickness of each layer within the stratified structures was imposed in order to
take into account the deposition rate for a certain elemental composition.
A 1DPC made of all-silicon nitride alloys has been designed in order to have
TE-polarized BSW sustained in the 530–650 nm wavelength region, taking into
account the refractive indices measured in the homogeneous thin films. The
structure consists of a 7-period stack of high (H) and low (L) refractive index silicon-
nitride layers with thicknesses dH =dL=90 nm, terminated by a high refractive index
layer with dH =20 nm. The design has been optimized considering water as the
external medium exposed to the free surface of the 1DPC. The multilayer has
been deposited on a thin glass wafer and characterized by angle-resolved spectral
reflectivity in the Kretschmann–Raether spectroscopic configuration. A collimated
and TE-polarized white light has been used to illuminate the 1DPC through the
input facet of a glass coupling prism. Reflectance maps R(θ,λ) have been obtained
by means of a detection scheme in which the sample is rotated with respect to the
incident beam, where θ is the angle between the normal to the 1DPC layers and
the direction of the incident beam at the prism/multilayer interface. The reflected
light has been detected by means of a fibered spectrometer. In order to make BSW
appear, an external water medium must be in contact with the free surface of the
multilayer. To this end, an appropriate fluidic cell has been employed.
The calculated TE-polarized reflectivity map R(θ,λ) is shown in Fig. 2.3 over
a 560 to 650 nm spectral range. Incidence angles beyond the critical angle were
considered in order to operate in Total Internal Reflection mode. A dip appears
in the reflected light for specific pairs (θ,λ) ,which shows that a BSW coupling
condition is reached. The reflectivity dip is dispersed in the (θ,λ) plane according
to the BSW dispersion diagram [Liscidini and Sipe (2009),?]. An angularly-resolved
spectral reflectivity map has been experimentally collected, as illustrated in the
inset of Fig. 2.3(b), that shows that the BSW dispersion is in good agreement
with the calculated results. The dip observed at specific angles (see, for example
Fig. 2.3(c)) is related to the BSW coupling and is only observed when TE-polarized
illumination is adopted.
Another 1DPC has been designed considering the high refractive index a-
SiNx :H and a-SiOxCy :H as building blocks. In this case, the structure consists of
a 5-period stack of high-n a-SiNx :H (H) and a-SiOxCy :H (L) with thicknesses of
dH =115 nm and dL=155 nm, respectively. A lower period of the dielectric stack has
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Fig. 2.3 (a) Calculated TE-polarized angularly-resolved spectral reflectivity for the all-silicon
nitride 1DPC described in the text; (b) R(θ,λ) experimental reflectivity map collected in a prism-
coupling configuration. The critical angle for a water/glass interface is visible at 62.5°; (c) cross-
sectional spectral reflectivity profile collected at 65° (in a total internal reflection condition).
Fig. 2.4 (a) Calculated TE-polarized angularly-resolved spectral reflectivity for the silicon ni-
tride–silicon oxycarbide 1DPC described in the text; (b) R(θ,λ) experimental reflectivity map
collected in a prism-coupling configuration; (c) cross-sectional spectral reflectivity profile col-
lected at 65° (in a total internal reflection condition).
been imposed in such a layout, taking advantage of the high optical contrast in the
a-SiNx :H/a-SiOxCy :H sequence. A clear BSW dispersion has also been pointed
out in the reflectivity maps for this 1DPC, as shown in Fig. 2.4.
These results, concerning spectrally/angularly resolved reflectivity measure-
ments, demonstrate the potentiality of amorphous silicon technology based on
PECVD for refractive index tuning of high optical quality layers consisting of bi-
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nary and ternary alloys (a-SiNx :H and a-SiOxCy :H) to be used in 1DPC sustaining
BSWs.
2.4 Plasma-Ion Assisted Vacuum Evaporation
This technique belongs to the Physical Vapour Deposition (PVD) methods that
are conducted in high vacuum conditions. In Fig. 2.5, a schematic drawing of the
PIAD principle is shown. Material from a thermal vaporization source reaches the
substrate with title or no collision with gas molecules in the space between the
source and substrate. The trajectory of the vaporized material is line-of-sight. The
vacuum environment also provides the ability to reduce gaseous contamination
in the deposition system to a low level. Typically, vacuum deposition takes place
in the gas pressure range of 10−9 to 10−5mbar depending on the level of gaseous
contamination that can be tolerated in the deposition system. The thermal va-
porization rate can be very high compared to other vaporization methods. The
material vaporized from the source has a composition which is in proportion to
the relative vapor pressure of the material in the molten source material. Thermal
evaporation is generally done using thermally heated sources such as tungsten
wire coils or by high energy electron beam heating of the source material itself.
Generally the substrates are mounted at an appreciable distance away from the
vaporization source to reduce radiant heating of the substrate by the vaporization
source. For the PIAD technology (as shown in the schematic drawing in Fig. 2.5), a
plasma ion source is installed in the center of the chamber. The high energetic
ions that are emitted from the source and that are accelerated towards the sub-
strate holder allow to densify the growing layer very effectively without heating of
the substrates.
The plasma ion source which represents the core element of a PIAD plant
is based on a LaB6 cathode, a cylindrical anode tube and a solenoid magnet as
can be seen in Fig. 2.6. The cylindrical LaB6 cathode is indirectly heated by a
graphite filament heater. A dc voltage between anode and cathode creates a glow
discharge plasma with a hot electron emitter, supplied with a noble gas such as
argon. Due to the magnetic field of the solenoid magnet, which surrounds the
anode tube, the plasma is extracted towards the direction of the substrate holder.
The reactive gases are introduced through a ring shower located on top of the
anode tube. Because of the high plasma density, the reactive gases get activated
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Fig. 2.5 Schematic drawing of PIAD deposition technique.
and partly ionized. Ionization of the reactive gas lowers the required reactive gas
pressure, to grow stoichiometric films. The plasma source is electrically insulated
with respect to the chamber ground. Therefore the plasma gets a positive self bias
voltage relative to the chamber walls and to the substrate holder. The ion energy
is mainly determined by the self bias voltage between anode and chamber ground.
The magnitude of the bias voltage, which is controlled during the evaporation
process, depends on the applied discharge voltage, the magnetic field strength,
the gas flows and the chamber pressure. Due to momentum transfer of the accel-
erated plasma ions onto the condensing film molecules, the surface mobility and
therefore the packing density of the growing film is increased. Since the plasma
spreads in the total volume between the plasma source and the substrate holder,
the evaporant also becomes partly ionized.
All the photonic crystals used in this work have been produced at the Fraun-
hofer Institute Jena (IOF) by means of an APS 904 PIAD system (Leybold Optics
GmbH). Fig. 2.7 shows the inside of the APS 904 if the chamber door is open.
On the top the rotatable substrate holder is mounted. The substrate rotation is
necessary to provide good thickness homogeneity in circumferential direction.
The homogeneity in radial direction is given by an adapted shadow mask. Two
270 ° electron beam gun evaporators are installed where it is possible to evaporate
almost every material with a high deposition rate. Nowadays these evaporators
are standard equipment for this kind of coating plants and are usually applied
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Fig. 2.6 Schematic drawing of the plasma ion source.
for the evaporation of metal oxide materials. In the center of the chamber the
Advanced Plasma Source (APS) is situated.
2.5 Re-engineering of thin film optical properties by
means of BSW
The fabrication of suitable 1DPC showing proper BSW dispersion and field en-
hancement is a critical requirement for highly sensitive biosensing. An intimate
knowledge of the optical constants of the deposited materials is essential for thin
film staks and high quality optical coatings. Relevant quantities are the absolute
value and the reproducibility of the refractive index n, the loss coefficient k and
layers’ thicknesses of the 1DPC. The excitation of leaky modes, like BSW, using
Kretschmann-Raether attenuated total reflection (ATR) configuration can be be
used for the determination of thin film parameters. The goniometer set-up for
the measurement of the angularly resolved reflectance comprising a fused silica
half-ball lens which allows large observation angles is shown in Fig. 2.8. The device
under test consist of 1 mm thick SiO2 substrate with a respective BSW stack. This
substrate is attached to the half ball lens (which is in fact slightly modified i.e.
reduced in thickness by the thickness of the substrate) by means of an appropriate
index matching liquid.
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Fig. 2.7 View inside the open APS 904 deposition chamber.
The angularly resolved signal which is recorded in TE as well as TM polariza-
tion is detected by an integrating sphere and both a reference and the reflectance
signals are processed with a lock-in-technique, which greatly reduces any external
signal noise. Due to the structural dimensions of the components the angular
span ranges from 10° to 80° in the employed two-θ measurement setup. The
results presented here have been published in Wächter et al. (2016).
Having in mind radiation losses of some 10−6 for SiO2 and 10−4÷ 10−5 for
H-layers of TiO2 and Ta2O5, respectively, a BSW stack for an operating wavelength
of λ=660 nm have been designed. The corresponding stacks are fabricated onto 1
mm thick substrates of fused silica by means of PIAD technology. Special care has
to be taken in the reflectance measurement to record data with an appropriate
angular resolution. Whereas for the angle scan well below TIR a step width of
∆θ=0.1° is sufficient, the resonance dip requires a much finer resolution of 0.01° or
even below. Furthermore, narrow features of the measured reflectance curve are
prone to be affected by a finite angular bandwidth of the beam. Thus, this angular
bandwidth is determined separately by a reflectance measurement around the
TIR-edge at a bare substrate, Fig. 2.9.
2.5 Re-engineering of thin film optical properties by means of BSW 37
Fig. 2.8 Goniometer set-up comprising half ball lens coupling for large observation angles.
Fig. 2.9 TE-reflectivity of bare SiO2 substrate close to the TIR-angle, measurement (dots), sim-
ulated values (black), fitted values with Gaussian angular beam width included in simulation
(red).
Assuming a Gaussian shape of the angular spectrum the corresponding an-
gular beam-width ∆θbeam results in a corresponding distribution of plane wave
components. If the fit of measured reflectance data and those modeled by TMM
comprises a corresponding convolution∆θbeam is a parameter which can be read-
ily determined. For the underlying setup a typical value of ∆θbeam=0.035° or 0.6
mrad can be derived from the data shown in Fig. 2.9 which is taken into account
within the fits to determine the parameter of the layer stacks, subsequently.
Two HL-stacks sub|(LH )4| L of TiO2 and SiO2 with nominal values of dL=220nm
and two different values of dH , i.e. 115nm and 275nm, respectively, are exam-
ined. Intentionally, the particular angular resonance positions are similar, but the
power-fraction in the H and L-layers differs. Thus, even with a single dip in both
reflectance curves a determination of both kL and kH is possible. Since neither
designated optical constants nor film thicknesses are perfectly met in a deposition
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the fit of the reflectance data must provide the complete layer data vector LDV,
whose components in Matlab notation reads as LDV(i,1:3) = [ni , ki , di ] for any of
the individual layers. Thus, with a layer number of Nl the total numbers of un-
knowns to be determined in a fit would be 3 Nl + 2 if angular beam width and nsub
would be cross-checked, too. With some reasonable assumptions the number
of unknowns can be reduced, i.e. assuming identical n and k for the respective
layer-types, and omitting a cross-check of ∆θbeam then 9 thickness-values, three
refractive indices and two k values need to be fixed in this specific configuration.
The numerical fit problem can be tackled by any optimization code, ranging from
downhill-simplex to Levenberg-Marquardt for nonlinear least squares, at least in
principle. For any fit a reasonable guess for the start LDV has to be provided, self-
evidently, where at least for the fit up to the TIR-edge the design LDV might work.
A direct fit of the complete reflectance measurement in just one attempt turns out
to be all but impossible. Generally, for any practical fit including the resonance
dip reasonable strict parameter constraints are needed in order to prevent the
optimization algorithm from digressive runaway of some of the stack-parameter
values.
Fig. 2.10 Fitted TE (red) and TM (blue) reflectivity curves for BSW-stack with dH ∼275nm (a) and
115 nm (b). Measured values are indicated by dots, fits are plotted as lines.
The resulting fit for the TiO2-based BSW with the thick H-layers is shown in
Fig. 2.10. The LDVs for both H-thicknesses are given in Table 2.2. The differentia-
tion of the L and H losses relies on a combined analysis of both samples.
The validity of the calculated refractive indices n and layer thicknesses has
been confirmed by variable angle spectroscopic ellipsometer measurements. The
losses measured for the BSW-stacks are seemingly reliable, at least concerning
the order of magnitude. However, measurements of similar layers by e.g. laser
calorimetry show perceptibly lower losses as those estimated by the evaluation
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Table 2.2 Fitted LDVs of both TiO2-BSW-stacks.
Stack with thick H-layer Stack with thin H-layer
Thickness nm Thickness nm n k
L4 215.1 211.6 1.446 6·10−6
H4 274.8 115.8 2.26 5.5·10−5
L3 220.1 218.9 1.446 6·10−6
H3 276.9 117.9 2.26 5.5·10−5
L2 219.6 218.7 1.446 6·10−6
H2 274 112.1 2.26 5.5·10−5
L1 215.5 214 1.446 6·10−6
H1 276.4 115.7 2.26 5.5·10−5
L0 215.6 214.3 1.446 6·10−6
Sub 1.457
of the leaky wave resonances. This can be attributed to the longer wavelength of
λ=1030nm used for laser calorimetry, at least partly. Furthermore, this tendency is
comprehensible simply due to the fact that with respect to leaky wave propagation
material losses and losses due to surface roughness add up, and, from the point of
view of critical coupling requirements act as the counterbalance of the inherent
radiation loss of the leaky wave stack. In addition to the stack-air surface internal
interfaces contribute as well to the scattering particularly due to local field maxima
at L-H interfaces of reflector-layer-pairs. Despite this, the procedure presented
is a great help in the determination of the LVD of a thin film stack. This was
used to fine tune the PIAD depositions and produce 1DPC showing proper BSW
dispersion and field enhancement.
2.6 Selection of the 1DPC
Once the deposited layers were characterized, the optimization procedure illus-
trated in the previous chapter was used to design the optimized 1DPC used for
the experimental section. A new stack was designed that contained TiO2 as thin,
high index layer in order to increase resonance width. In fact, although a decrease
of resonance width is required in order to achieve a decreased LoD, imaging such
extremely narrow angular resonances increases the demand of resolution for any
optical system. Resolution means the capability to obtain an image of this reso-
nance in order to achieve sampling by the pixelated detector. Resolution limits
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are imposed due to diffraction limits an aberrations by non-ideal optical elements.
This design represents a trade off between the the smallest LoD possible and the
possibility to correctly image the label-free resonance. Different extinction of TiO2
can be prepared during deposition thus resulting in:
• low loss TiO2 n(T iO2) ∼2.28+i5.0·10−4
• high loss TiO2 n(T iO2) ∼2.28+i1.8·10−3
Wavelength of calculation is 670 nm and the values n(Ta2O5)= 2.108+ i 5·10−5;
n(SiO2)= 1.474+ i 5·10−6; n(subs)=1.5299 have been assumed for simulation.
After preliminary steps the structure subs | SiO2 | (Ta2O5/SiO2)
2or 3 | T iO2 | SiO2 |
water has been selected for detailed consideration and optimization as described
below. In case of low T iO2 losses a 3 period stack and in case of high T iO2 losses
a 2 period stack is being used in order to achieve deep resonances. Both top layers
have been set to 20 nm thicknesses in order to achieve a proper wave guiding layer.
Furthermore, a 20 nm SiO2 cover layer is introduced to enable for silane based
surface chemistry.
It turns out, that both the angular position of the resonance and the sensitivity
are not affected by the losses of the T iO2 layer. This is due to the fact that both
quantities depend on the refractive index real part much more that on the losses
in such loss range. Contrarily and as has been intended, the resonance width and
depth vary when changing the T iO2 layer losses and adapting the substrate side
stack. This is apparent when comparing the right and left columns in Fig. 2.11.
From such data the performance measures FoM and LoD have been derived
(Fig. 2.12).
In result, using a high loss stack with thin T iO2 high index layer theoretically
enables one to achieve LoDmi n<10 nm or a FoMmax ∼0.4 nm−1.
The selected multilayer has a maximum sensitivity and comprises high loss
T iO2 top layer and two period stack with 120 nm thick Ta2O5 and 275 nm thick
SiO2. The following properties can be derived for the selected stack:
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Fig. 2.11 Comparison of resonance widths, depths as well as angular position and sensitivity
for the cases of high and low absorbing T iO2 layer as described in the text. Black color depicts
regions with invalid data due to the limited range of angular calculation.
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Fig. 2.12 Comparison of resulting LoD and FoM for the cases of high and low absorbing T iO2
layer as described in the text. Black colour depicts regions with invalid data due to the limited
range of angular calculation.
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Depth D = 0.92
Width of Resonance W = 0.12°
Sensitivity S = 0.034°/nm
Angular range A = 1.36° (label-free)
Figure of Merit FoM = 0.26 nm−1
Limit of detection LoD = 12.9 nm
Fig. 2.13(a) presents a rendering of a section of the chosen 1DPC stack (not to
scale).
Fig. 2.13 (a) Rendered image of a cross section of the 1DPC on top of the biochip (not to scale).
The 1DPC image is sectioned to show the different layers. (b) Calculated angular reflectivity profile
for TE and TM polarized light at λ= 670 nm, (c) simulated intensity distribution of the fluorophore
DyLight 650 over an 8 ° angular range for TE, TM, and SUM emission polarization.
In Fig. 2.13(b) it is shown the calculated angular reflectance spectrum for TE
and TM polarized incident light at λ= 670 nm for the chosen 1DPC. The external
medium used in the calculation is water, nH2O= 1.33. BSW is excited trough
an electromagnetic wave at λ around 67 ° when considering the TE polarized
mode and 63 ° for the TM, the configuration used is Kretschmann-Raether. As
already mentioned, the excitation of BSW leads to an enhancement of the electric
field at the interface between the 1DPC surface and the external medium. This
enhancement is used to excite fluorophores at the stack surface and boost their
emission into the direction of the substrate. The resulting fluorescence emission
is angularly dispersed due to the dispersion of the BSW thin film stack as shown
in Fig. 2.13(c). It presents the simulated intensity distribution of an ensemble
of fluorophores with a given spectrum over an 8 ° angular range. Two peaks are
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clearly visible, they are due to the coupling of the fluorescence emission to the
BSW TE mode and to the TM mode present in the 1DPC structure.
2.7 Optical setup for biosensing
The optical system have been developed by the Fraunhofer Institute for Applied
Optics and Precision Engineering IOF in Jena and is depicted in Fig. 2.15. The
author of this thesis have participated to the development of the system during a
period prior to the beginning of the Ph.D.
The biosensing platform is furnished with a disposable and low cost sensor unit: a
molded plastic (TOPAS®) substrate with micro-optics (KDS Raderberger Gmb.H,
Germany) (Fig. 2.14) represented as a prism in Fig. 2.15. The chip links the optical
system with the fluidic (handling) system and is the solid support for the dielectric
thin film stacks as transducer.
Fig. 2.14 Sketch of the chip functionality (left), photo of the TOPAS® chip with its polymeric
microfluidic cover, the greenish part is the 1DPC.
A collimated, TE polarized beam of a 670 nm laser diode is focused by a
cylindrical lens (CL1) into the polymer chip, thus illuminating a line at the sen-
sor surface. The reflected light is angularly imaged onto the CCD image sensor
(APOGEE Ascent with Sony ICX814) by the cylindrical lens CL2. Therefore, each
row of the CCD image can be assigned to one angular component of the reflected
light in order to measure the angular reflectivity curve plotted in Fig. 2.13(b). In
result, an angular range of 2.9 deg is analyzed along the long dimension of the
CCD. For the label-free operation, the angular range was restricted around the
resonance to reduce the memory occupation and increase the CCD frame rate.
More than 20 spots can be arranged along the illuminated line at the sensor
surface. These are imaged by a cylindrical optical system (CL3 and CL4) onto the
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Fig. 2.15 Sketch illustrating the optical system without plotting laser diode collimation systems.
Label-free and fluorescence emission is shown in red while fluorescence excitation is illustrated in
green. See text for details.
columns of the CCD in order to allow one for analyzing each spot independently.
The fluorescence detection is achieved by means of a 635 nm laser diode. The
resonance for fluorescence excitation is as narrow as the resonance utilized for
label-free sensing. Its angular position will also shift during the experiments when
molecules bind onto the sensor surface (the same effect as the one exploited
for label-free sensing). That’s why the angle of fluorescence excitation needs to
be scanned in order to find the correct excitation angle to exploit surface wave
enhanced fluorescence excitation. Here, the collimated beam of the 635 nm laser
diode is focused by a 100 mm focal length cylindrical lens into the sensor (green
rays in Fig. 2.15) thus illuminating the same line as the one illuminated in the
label-free mode. The dichroic splitter SP combines the different wavelengths. Lat-
erally shifting the collimated laser beam keeps the illuminated position constant
but changes the angle of excitation.
The dichroic splitter SP transmits the emitted fluorescence that is imaged angu-
larly and laterally by the same optical system onto the same detector as in the
label-free case. But the angular range of 2.9 deg observed in the label-free case
is insufficient to collect all fluorescence energy emitted. Therefore a cylindrical
system (zoom in Fig. 2.15) can be introduced. This will increase the angular range
observed, thus enabling to collect almost all fluorescence, but reduce the angular
resolution which is not required in the fluorescence mode.
"
Chapter 3
Biofunctionalization protocols and
materials
" Successful detection of target biomolecule upon the 1DPC surface relies on
the selective interaction of the biosensor with the target biomolecule. It is there-
fore essential to immobilize a specific antibody for the target biomarker on the
1DPC biochip surface. A direct assay was chosen (Fig. 3.1) for the biomarkers
detection and to assess the performance of the biosensor. A direct assay allows
the sensing of the analytes both in the label-free mode as well as fluorescence,
as depicted in Fig. 3.1. The assay involves a two-step method for achieving the
dual mode of detection. In the label-free mode, the biomarkers are directly im-
mobilized on the antibody-functionalized surface and physical measurements
are performed. However, a second specific primary antibody is bound on the
biomarker-immobilized surface in the second mode of detection. Using a second
primary antibody labelled with fluorophores, the detection can be performed in
fluorescence mode.
To achieve such a versatile approach for detection, the surface should be
properly functionalized prior to the covalently attach of the primary antibody. The
activity of proteins immobilized on a solid surface, is typically weaker than that
in the aqueous phase, mainly because the orientation of the protein molecules
on a solid substrate is random. The strategy adopted involves conjugating the
chemically functionalized surfaces with protein G that should properly orient
the probe antibodies to achieve higher sensitivity. This protein is capable of
binding the Fc fragment of the antibody, leaving free the Fab fragment where the
interaction with the antigen takes place. Next, the protein G modified surfaces
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Fig. 3.1 Schematic representation of the direct immunodetection assay. The biochips are first
functionalized with protein G, followed by conjugation with primary antibodies (capture antibod-
ies). These antibodies specifically interact and capture the biomarkers, which can be detected
using label-free mode (Step 1). Subsequently, second primary antibodies (detection antibodies)
tagged with fluorophores are added, which specifically recognize the bound biomarkers and can
be detected in the fluorescence mode (Step 2).
will be covered with a densely distributed properly oriented probe antibodies,
specific for a given biomarker. Although the use of protein G seemed reasonable
in first tests, the measurements carried out on the final platform suffered from
non-specific absorption due to non-uniform cover of this molecule. As will be
shown later, the use of protein G was discontinued in order to work out the issue
of the non-specific absorption.
The surface functionalization protocol was optimized in close collaboration
with the group of Prof. Molly Stevens at the Imperial College, London.
3.1 APTES wet functionalization
A protein biosensor on solid surfaces must have an artificial biomolecular mono-
layer. These thin organic films increase the biocompatibility of the surface and
3.1 APTES wet functionalization 48
protect the proteins form denaturation and structural modification during surface
immobilization. Therefore, it is mandatory to design possible biomolecule adsorp-
tion strategies that could be adapted to the studied 1DPC system. The designed
1DPC has a silicon dioxide (SiO2) active layer for protein immobilization. Among
the various surface modification techniques, the deposition of a self-assembled
monolayer (SAM) of organosilane on a SiO2 surface is very versatile, and has many
advantages over other approaches. Many organosilanes have been employed to
form SAMs on such surfaces [Mittal and International Symposium on Silanes and
Other Coupling Agents. (1992)].
(3-aminopropyl)triethoxysilane (APTES) chemistry is particularly appealing
for antibody immobilization, due in part to many advances in the understanding
of this class of surface modification agents. APTES can readily react with hydroxyl
groups and can support the formation of monolayer coverage under carefully
controlled conditions [Mittal and International Symposium on Silanes and Other
Coupling Agents. (1992)]. Modification of the surfaces through APTES chemistry
results in amino functional group that can be readily conjugated to chemical agent
that would lead to crosslinking with the protein of interest (Fig. 3.2).
Fig. 3.2 Wet functionalization of test substrates with (3-aminopropyl)triethoxysilane. The amine
termination of the functionalized surface enables cross-coupling with protein through glutaralde-
hyde.
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Glutaraldehyde (GAH) is used as a bifunctional agent to couple the APTES-
functionalized surface with protein G, where a terminal aldehyde group would be
free to react with the antibody (Fig. 3.2). Using glutaraldehyde as a crosslinking
agent a dense monolayer of proteins is obtained on the surface irrespective of
different reaction mechanisms.
For the silanization, the substrates were cleaned in piranha solution for 10
min at room temperature, thoroughly rinsed with de-ionized water, and then
dried under N2 gas. Initially, the substrates were incubated with 2, 5 and 10%
(v/v) APTES solution in 95% ethanol-water mixture for 1 hr at room temperature.
Reaction efficiency at different reaction time such as 30 min, 1 hr and 2 hr was
also studied. Following the APTES reaction the slides were sonicated for 2 min
and rinsed with ethanol and water to remove non-covalently adsorbed silane
compounds. After thorough washing the chips were cured at 80 °C for 1 hr on
a hotplate to prepare a stable monolayer of APTES ligand. Static contact angle
measurements were performed in three replicates using 5 µL of water and using
the Laplace-Young fitting method.
As observed from the static water contact angle (WCA), the substrates were
very hydrophilic with a measured WCA of ∼10 °. The surface hydrophobicity in-
creased significantly for the APTES SAMs with WCA ranging between 51 ° and 58 °.
Interestingly, the WCA was higher for the lower amount of APTES, indicating an en-
hanced surface hydrophobicity for lower amount of APTES. This observation may
point at the well-defined SAM formation on the substrates at lower concentration
of APTES. However, the reaction with 2% APTES at the chosen time points (30 min,
1 hr, and 2 hr) did not alter the surface hydrophobicity significantly (Fig. 3.3(A, J,
K)), suggesting that the surface was covered with the SAM even within a shorter
reaction time. The APTES reaction, therefore, presents an efficient strategy for
functionalizing the 1DPC surface.
The APTES layer was immobilized with fluorescein isothiocyanate (FITC) to
ensure that the APTES treatment of the substrate surface provided sufficient free
amino groups that would enable conjugating with a crosslinker in the next step
of functionalization. FITC is an aminereactive fluorescent compound that forms
a stable covalently attached fluorescent conjugate (FITC-APTES conjugate) after
reacting with APTES, containing a primary amine group [Jang and Liu (2009)].
FITC conjugation was performed on the APTES-functionalized surfaces by incu-
bating with 0.1 mg/ml FITC in DMSO for 12 h. Then, the samples were washed
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Fig. 3.3 APTES functionalization of test substrate with SiO2 outermost layer. Static contact
angle of water were measured on surfaces functionalized with (A) 0%, (B) 2%, (C) 5%, and (D)
10% APTES (v/v). Fluorescent images of APTES-FITC were captured for slides treated (E) without
APTES and with different amount of APTES such as (F) 2%, (G) 5%, and (c) 10% for 1 hr at room
temperature. (I) Fluorescence intensities of each of the images were plotted against the amount of
APTES reacted. Contact angle was measured for the surfaces treated with 2% APTES for (J) 30 min,
and (K) 2 hr at room temperature. Scale bar: 1 µm.
with DMSO and ethanol inan ultrasonic bath and blown dry using nitrogen. Fluo-
rescent images (using a microscope) of the FITC-APTES conjugates presented an
interesting trend. While both the 2% and 5% APTES provided highly fluorescent
surfaces, the reaction with 10% APTES resulted in a surface with FITC labelling
to a lesser extent (Fig. 3.3(E, F, G, H)). The fluorescence intensity of the differ-
ent functionalized surfaces showed a linear decrease (Fig. 3.3I). Based on these
observations, 2% and 5% APTES concentrations were chosen.
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3.2 Conjugation with glutaraldehyde
Following the APTES functionalization, the glutaraldehyde (GAH) crosslinking
reaction was studied. The optimization was carried out using a 2:1 APTES:GAH
ratio on the substrates pre-functionalized with 2% and 5% APTES. Also, the re-
action efficiency was assessed in presence and absence of sodium cyanoborohy-
dride (NaCNBH3), a mild reducing agent that reduces the unstable imine bond
formed between the primary amino group of APTES and the aldehyde group
of glutaraldehyde. The resulting secondary amine compound should provide a
stable monolayer of the crosslinker conjugated to the surface. So, the 2% and 5%
APTES-functionalized slides were immersed in GAH solution in 100 mM KHCO3
(pH∼8.5) in presence or absence of 0.1 mM NaCNBH3 for 1 hr. Then, the slides
were sonicated for 2 min to remove non-covalently adsorbed GAH molecules and
washed thoroughly with water. It can be observed that NaCNBH3 plays a major
role in the conjugation reaction.
It can be seen that while the static WCA slightly increased to ∼61 ° indicating
enhanced surface hydrophobicity upon GAH conjugation, the WCA values were
very similar for both the 2% and 5% APTES-functionalized surfaces in absence of
the reducing agent (Fig. 3.4). However, the GAH reaction in presence of NaCNBH3
provided much higher hydrophobicity for both the surfaces (Fig. 3.4E), indicat-
ing that the GAH functionalization on APTES-coated surfaces is more effective
in presence of the mild reducing agent. The hydrophobicity of the 2% APTES-
functionalized surface was very high compared to the 5% APTES-coated slide,
suggesting an efficient reaction with the crosslinker on the well-defined APTES
layer.
3.3 Final functionalization protocol and definition of
spot arrays
Four biochips were functionalized at a time. All the concentrations, volumes and
times of the functionalization and immobilization procedure were adjusted to
obtain the best sensor performance. 1DPC surface was cleaned with piranha
(H2SO4:H2O2 = 3:1) for 10 minutes, washed thoroughly using de-ionized (DI)
water and ethanol and dried with N2. The cleaned biochips were dipped in a
2% (v/v) solution of APTES in a mixture of ethanol/water (95:5 v/v) for 1 hour.
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Fig. 3.4 Glutaraldehyde conjugation of APTES-functionalized surfaces. Static contact angle of
water were measured on GAH conjugated 2% APTES-functionalized surfaces with (A) 0, (B) 0.1
mM NaCNBH3 and on 5% APTES with (C) 0, (D) 0.1 mM NaCNBH3.
They were then transferred in pure ethanol and sonicated three times. After
rinsing with pure ethanol and drying with N2 the biochips were baked on a hot
plate at 80 °C for 1 hour. As already mentioned, glutaraldehyde (GAH) was used
as a homobifunctional agent to couple the APTES functionalized surface with
the specific antibodies that are intended to be immobilized on the surface. The
prepared biochips were dipped in a solution of 1% (v/v) GAH in 100 mM sodium
bicarbonate buffer (pH 8.5) in the presence of 0.1 mM NaCNBH3 for 1 hour. A last
sonication was performed in DI water followed by a thorough wash with DI water.
Fig. 3.5 Picture illustrating the five channel functionalization flow cell. The Polydimethylsiloxane
(PDMS) flow cell (blue) with the five fluidic channels (red) attached to an aluminum plate (left).
Filling of a channel flow cell using a standard microliter pipette (right).
The following step was the protein G immobilization that was carried out after
mounting on the functionalized biochip the spotting tool showed in Fig. 3.5. Such
3.4 Materials 53
a microfluidic tool allowed to prepare five different measurement spots on the
sensor surface. The tool is composed of a Polydimethylsiloxane (PDMS) flow cell
with five parallel channels (each 200 µm wide and 200 µm high) that is attached to
an aluminum backplate. For the immobilization of the biomolecules, the biochip
was loaded into a socket plate and topped with the five channel functionalization
flow cell, which was then locked using screws. Thus, a closed fluidic system on
the chip is obtained which allowed filling the proteins to be immobilized using a
standard microliter pipette into the channels (Fig. 3.5, right). The cell was used to
immobilize in two regions (channels) of the biochip surface BSA (10 mg/mL) and
in three regions protein G (0.5 mg/mL). After 1 hour of incubation the biochip was
detached from the tool and rinsed with D-PBS. The biochip was loaded again in
the tool and the same three channels used for PtG were then filled with a solution
containing the capture antibody, specific for the biomarker to be detected during
the successive experiment. After incubating the biomolecules the spotting tool
was removed, the biochip was washed in D-PBS and the microfluidic cell was
clicked on top before mounting the complete biochip in the analytical instrument.
3.4 Materials
In order to maximize the performance of the sensing measurements and for sake
of reproducibility, all the sensing measurements have been always performed the
day after the biomolecules immobilization. This is the reason why although the
functionalization protocols have been developed mainly by the Imperial College
group, all the biochips that were measured have been funtionalized at Politec-
nico of Torino providing the necessary information for the optimization of the
technique.
A detailed list of the chemical and biological materials that have been used in
this thesis is briefly presented below.
3.4.1 Chemicals
Sulfuric acid (95-98%), hydrogen peroxide (30% in H2O), (3-Aminopropyl) tri-
ethoxysilane (APTES, 99%), ethanol (99.8%), glutaraldehyde solution (grade I,
50% in H2O), sodium bicarbonate (99.7%), sodium cyanoborohydride (95%), hy-
drogen chloride (2M), glycine (98.5%), bovine serum albumin (BSA, 98%), fetal
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bovine serum (FBS) and Dulbecco’s Phosphate Buffered Saline 1X (D-PBS) were
purchased from Sigma-Aldrich and used as received. Dulbecco’s modified Eagle
medium (DMEM) was purchased from Lonza. NeutrAvidin Protein DyLight 650 (1
mg/mL) was purchased from Thermo Fisher Scientific. Anti-human VEGF capture
antibody, recombinant human VEGF165 protein (97%), biotinylated anti-human
VEGF detection antibody , anti-human Angiopoietin-1 capture antibody , Anti-
human Angiopoietin-2 capture antibody, biotinylated anti-human Angiopoietin-2
detection antibody, Human VEGF and Human Angiopoieitn-2 Quantikine ELISA
Kit were purchased from R&D System. Water was purified by Millipore device.
3.4.2 Biological samples
All the biological samples were supplied by the Institute for Cancer Research and
Treatment in Candiolo, Italy, by the group of Prof. Federico Bussolino.
Wild-type and biomarker-overexpressing Colo205 and MCF-7 cells were used.
These latter were a kind gift of Prof. Roy Bicknell (University of Birmingham).
MCF-7 cells are a human breast adenocarcinoma cell line extensively used in
cancer research [Coms¸a et al. (2015)]. Cells were seeded in culture dishes at the
density of 3.0·106 cells/cm2 with DMEM containing 10% FBS. Serum-free medium
was conditioned for 48h by confluent cultures. After collection, cell supernatants
were cleaned by centrifugation (1500 rpm for 10 min at 4 °C) to remove particles.
Samples were aliquoted and stored at -20 °C. Human plasma samples were from
blood of cancer patients. Samples were collected in accordance with the protocol
approved by the Institute’s Ethical Commission and the Ethical Committee Pied-
mont Region, Torino, Italy. Plasma was prepared by centrifugation of the whole
blood contained in the test tube with EDTA as anticoagulant; after centrifugation
the corpuscolate fraction was discarded and the supernatant (i.e. plasma) was
collected, aliquoted and stored at -80 °C. Plasma samples were analyzed with both
the BSW biosensing platform and ELISA technique in order to validate the results.
Commercially available kits from R&D Systems were used.
"
Chapter 4
Biosensing measurements
" The goal of this thesis is to pre-clinically validate a compact and multifunctional
point-of-care platform for real-time detection of cancer biomarkers in biological
fluids with high sensitivity in a tandem configuration. As already mentioned,
the two basic elements constituting the tandem approach are the label-free de-
tection, based on a BSW resonance shift, and the spectral analysis of enhanced
fluorescence emitted by biomolecules immobilized on the biochip surface.
The objective of the experiments is to measure very low concentration of an-
giogenic biomarkers coming from real world matrices like cell culture supernatant
and human blood plasma from a pool of apparently healthy patients and patients
with colonrectal cancer. This chapter is conceptually divided into three parts
reporting the difficulties and the successes achieved during measurements:
- First tests and modifications of the surface chemistry
The first batch of biochips was devoted to test the complete platform and
the functionalized biochips with biomarker concentrations of the same
order of magnitude of the real samples. During these assays a problem with
the biomolecules immobilization was discovered and a complete batch of
biochip have been used to develop a strategy to overcome it.
- Results comparison between different matrices
Once surface chemistry issues were resolved, matrix effects were investi-
gated for the detection of an important angiogenic factor, vascular endothe-
lial growth factor (VEGF), in different matrices like Dulbecco’s phosphate
buffer saline (D-PBS), cell culture supernatant and human plasma samples.
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- Determination of Angiopoietin-2 in human plasma samples
Finally the fluorescence detection of the angiogenic factor Angiopoietin-2
(Ang2) in patients’ plasma samples is presented. The biosensing system
allows the detection of Angiopoietin-2 with similar analytical quality as
laboratory methods, i.e. enzyme-linked immunosorbent assay (ELISA), but
featuring short turnaround time, without any sample pretreatment and
simple use.
4.1 First tests and modifications of the surface chem-
istry
The previous chapter described the protocol for the functionalization of the
biochips and the immobilization of the biomolecules. The protocol was com-
posed by four main steps:
1. APTES functionalization;
2. Glutaraldehyde crosslinker;
3. ProteinG (PtG) immobilization;
4. Antibody immobilization;
5. Bovine serum albumine (BSA) blocking (10mg/mL in D-PBS) at 4 °C overnight.
The steps 1-2 of the protocol were carried out over the whole surface of the
biochips. The steps 3-4 were carried out after mounting on the biochips the five-
channel flow cell. Primarily, the spotting tool was used to immobilize BSA (10
mg/mL) in two regions (channels) of the biochip surface and in three regions
PtG (0.5 mg/mL). After 1 hour of incubation the biochip was detached from the
tool and rinsed with D-PBS. The biochip was loaded again in the tool and the
same three channels used for PtG were then filled with a solution containing the
capture antibody, specific for the biomarker to be detected during the successive
experiment. After incubating the biomolecules the spotting tool was removed, the
biochip was washed in D-PBS and the microfluidic cell was clicked on top before
mounting the complete biochip in the analytical instrument.
For the first set of experiments the following procedure was used:
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• Baseline in D-PBS 1X.
• Injection and flush of 250µL of the analyte solution in D-PBS containing the
biomarker.
• Injection and recirculation: 150µLof the same solution back and forward,
30 times.
• Wash: injection of 1000µL of D-PBS and then recirculation of 100µL 5 times.
• Injection and flush of 250µl of the detection antibody solution (2µg/mL) in
D-PBS 1X.
• Injection and recirculation: 150µl of the same solution back and forward,
30 times.
• Wash: injection of 1000µL of D-PBS 1X and then recirculation of 100µL 5
times.
• Check for any fluorescence signal (fluorescence background measurement).
• Injection and flush of 250µl of Neutravidin solution (2µg/mL) in D-PBS 1X.
• Injection and recirculation: 150µl of the same solution back and forward,
30 times.
• Measure fluorescence.
Before starting each experiment, 1 mL of glycine-HCl (20 mM, pH 2.5) was
injected and recirculated for 10 minutes to clean the surface. The measurement
started in the label-free detection mode. In Fig. 4.1(b) it is shown the CCD camera
image acquired in label-free mode for a functionalized biochip in D-PBS. Each
pixel column corresponds to an angular component of the reflected beam and
each row corresponds to a position along the illuminated region on the biochip
surface. The BSW resonance appears as a dark vertical band. The angular position
of the resonance puts into evidence the regions where the capture antibodies were
immobilized, since the PDMS walls of the spotting tool leave residuals between
adjacent channels that shift the resonance. However, such PDMS markers do not
perturb in any way the measurement. The bio-conjugated regions are numbered
in order to distinguish between each other.
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Fig. 4.1 (a) Photo of the 1DPC surface after the incubation with the spotting tool and before
rinsing; (b) CCD reflectance map in label-free mode, the image was taken at the start of the
experiment in D-PBS.
Fig. 4.2 shows the time dependency of the position of the minimum of the BSW
resonance for the three spots where PtG+anti-VEGF antibody were incubated and
the two spots with BSA. The first concentration of VEGF sent (t∼9 min) was 31.25
pg/mL (i.e., the lowest standard suggested for the calibration curve related to the
ELISA tests performed on biological samples as comparison) but any label-free
binding signal was detected. Nevertheless, when injecting the detection antibody
(t∼42 min) and the neutravidin (t∼95 min), a binding kinetic was observed for
both.
The fluorescence detected by the CCD in the fluorescence mode is displayed
in Fig. 4.3 and confirms the presence of the detection antibody and the neutra-
vidin. The spots recorded by the CCD in the fluorescence mode of detection are
identical to those defined in the label-free mode. Fig. 4.3(b) shows the integrated
fluorescence intensity obtained for the regions considered before. The error bars
represent the standard deviation of the integrated values.
Although the difference of weight between the VEGF molecule and its antibody
is significant, it does not justify the difference observed in the sensorgram shown
Fig. 4.2 between the magnitude of the signals observed upon injection of VEGF
(t∼9 min) and that of the detection antibody (t∼42 min). Due to this discrepancy,
other experiments were conducted in order to understand whether any non-
specific binding of the detection antibody was present. First it was necessary
to ensure that the capture antibody was present on the biochip. The biochips
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Fig. 4.2 Label-free sensorgram of different spots of the biochip surface upon the injection of
31.25 pg/mL VEGF solution in D-PBS. Detection antibody and the neutravidin were also injected.
Although label-free signal of the VEGF was not evident, the binding of the detection antibody and
of the neutravidin was observed.
Fig. 4.3 (a) CCD camera image of the fluorescence emission of the neutravidin molecules that
couples to the BSW mode; (b) integrated fluorescence intensity from the same spots considered in
the label-free analysis.
were functionalized with APTES and GAH, then PtG and BSA were immobilized
with the five-channel flow cell as described previously. The spotting tool was
removed, biochips were whased with D-PBS, the fluidic cover was sealed and the
biochip mounted on the platform. The capture antibody solution was injected
directly in the microfluidic channel and the label-free signal was recorded. Two
different concentrations of the capture antibody were injected, i.e., 20 µg/mL
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(Fig. 4.4) and 40µg/mL (Fig. 4.6). After the washing step, the detection antibody
and the neutravidin were injected, at the concentration of 2 µg/mL (Fig. 4.6 5) and
1 µg/mL (Fig. 4.6).
Fig. 4.4 Label-free sensorgram for a biochip that was functionalized with PtG and then incubated
overnight in BSA. The first injection is the capture antibody that binds to the PtG. Then the
detection antibody and the neutravidin are flown in the microchannel. Although any VEGF
solution was injected a binding signal for both the detection antibody and the neutravidin is
observed.
Fig. 4.5 Integrated fluorescence intensity detected by the CCD from the same spots considered
in the label-free analysis. The presence of the fluorescence signal confirms that a non-specific
binding was observed in label-free.
A clear binding of the capture antibody is observed in the PtG regions with
respect to the blocked BSA reference regions. Despite the fact that any antigen was
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injected, a label-free signal for the detection antibody can be distinguished, only
in the PtG regions, whereas no evident binding was detected in the BSA regions.
This indicates the presence of not specific binding of the detection antibodies over
the PtG regions. This is confirmed by the difference of the fluorescence intensities
recorded in the regions bio-conjugated with either PtG or BSA.
From the comparison of Fig. 4.5 and Fig. 4.7, it is also clear that despites in
the second experiment the concentration of the injected capture antibody was
doubled, it was impossible to prevent the non-specific binding of the detection
antibody, in fact the fluorescence intensities recorded are similar.
Fig. 4.6 Like in Fig. 4.4 biochip was functionalized with PtG and then incubated overnight in BSA.
Two injections of the capture antibody were performed trying to saturate all the PtG binding sites.
In this case, the label-free signal of the non-specific binding of the detection antibody and of the
neutravidin is smaller.
The experiment was repeated with the injection of a 10 ng/mL VEGF solution
in PBS (Fig. 4.8. No label-free binding can be identified upon the flown of the
VEGF solutions. The capture antibody and the neutravidin were also injected,
both with a concentration of 1ug/mL: the fluorescence intensity recorded by the
CCD (Fig. 4.9) was of the same order of magnitude of the previous experiment
(Fig. 4.7) but in that case any VEGF solution was added to the system.
The capture antibody did not succeed to saturate all the PtG binding sites
and these lasts were free to bind the detection antibodies. Unfortunately this
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Fig. 4.7 Integrated fluorescence intensity detected by the CCD from the same spots considered
in the label-free analysis. Fluorescence analysis reveals still the presence of a non-specific signal.
Fig. 4.8 In this label-free sensorgram after the injection of the capture antibody a solution of
10 ng/mL of VEGF in PBS was also injected. The biochip was functionalized with PtG and then
incubated overnight in BSA. No evident binding on the VEGF was detected.
effect was predominant and masked the real signal that came from the effective
presence of the biomarker on the surface.
A strategy was developed to overcome the problem described and the immo-
bilization process was changed. The immobilization and use of the PtG layer
was discontinued. The five channel functionalization flow cell was used to bio-
conjugate either specific antibodies for the target biomarker or other non-specific
antibodies directly to GAH. In this way an on-chip negative reference region, very
4.2 Comparison between different matrices 63
Fig. 4.9 Integrated fluorescence intensity detected by the CCD from the same spots considered
in the label-free analysis. Intensities are similar to the ones reported in Fig. 4.7 when any VEGF
solution was injected.
similar to the signal regions, was created. It was used to subtract any signal that
arose from non-specific binding events. The functionalization and immobilization
process changed to the following:
1. APTES functionalization;
2. Glutaraldehyde crosslinker;
3. Antibody immobilization;
4. Bovine serum albumine (BSA) blocking (10mg/mL in D-PBS) at 4 °C overnight.
This solution was adopted for the subsequent experiments. The results are re-
ported in the next sections.
4.2 Comparison between different matrices
Blood plasma, together with serum, is one of the main sources of clinical analytes
[Ehresman et al. (2007)]. Although it contains many disease biomarker, it is one of
the most complex analytical matrix in which analytes are mixed with millions of
other molecules [Treviño et al. (2009)]. This represents a serious obstacle for the
development of clinical biosensors handling human plasma samples. Although
many experiments were conducted with biomarkers spiked in simple matrices
such as D-PBS, to obtain clinically relevant results it is essential to perform the
biomarker detection in more complex matrices such as blood plasma or other bi-
ological fluids. In order to test the BSW biosensing platform for matrix effects, the
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attention was focused on different samples that contained the Vascular Endothe-
lial Growth Factor (VEGF), an angiogenic inducer well known to play a key role in
cancer progression and dissemination as well as in tumor angiogenesis [Ferrara
(2010)]. Samples characterized by an increasing level of complexity were mea-
sured. More specifically, the lowest level of sample complexity was represented by
solutions of D-PBS where a known amount of biomarker – in form of recombinant
protein – was dissolved. Sample complexity increased with the use of cell culture
supernatants, where low amounts of other molecules were released in addition to
the biomarker. Finally, the highest level of sample complexity was represented by
human plasma, i.e. complex heterogeneous systems. Cell supernatant samples
and blood samples were tested for the presence of VEGF by ELISA and the results
were compared with those obtained with the BSW biosensing platform.
More than 30 biochips for the detection of the VEGF in different matrices
with label-free and fluorescence detection were tested. The calibration of the
biosensing platform have been made using solutions of VEGF in D-PBS. In the
case of matrices with a higher level of complexity, like supernatant and plasma
samples, the label-free signal have been affected by the critical problem of protein
fouling and are not reported. As can be seen from the experiments, fluorescence
mode of detection was less penalized by this effect and even more sensitive. All
experiments were carried out in duplicate.
The biochips were funtionalized with APTES chemistry as reported in previous
section. In order to discriminate between specific and non-specific binding dif-
ferent antibodies were incubated in different regions of the functionalized 1DPC
surface by means of the five-channel functionalization spotting tool. In following
experiments, the five-channel functionalization flow cell was used to immobilize
the anti-VEGF capture antibody as well as the anti-Angiopoietin 1 capture anti-
body used as negative control. Two channels were used to incubate 20 µg/mL of
the anti-VEGF capture antibody, other two channels were filled with 20 µg/mL of
the anti-Ang1 capture antibody and one was dedicated to BSA, 10 mg/mL. The
volume used was 20 µL for each channel. The immobilization step lasted 1 hour
and after the removal of the spotting tool, the biochips were rinsed with D-PBS
and incubated overnight in a solution of 10 mg/mL of BSA in D-PBS at 4 °C, in
order to block the surface.
Once the 1DPC surface is functionalized the microfluidic cover is clicked on
top of the biochip before mounting the assembled biochip in the platform for the
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detection. The detection assay was reported in previous section. In the label-free
mode, the biomarkers are directly recognized by the antibody-functionalized sur-
face leading to the label-free signal. In the fluorescence mode, the biotinylated
anti-VEGF detection antibody is injected in the flow cell and binds to the VEGF
biomarker possibly immobilized onto the surface; the biotinylated antibody is
in turn detected via a biotin-neutravidin recognition step, with an appropriate
fluorophore that permits its detection in the fluorescence mode. The five measure-
ment spots created with the spotting tool are numbered from 1 to 5 (Fig. 4.10). In
all the experiments that are reported in this section, the Spot 3 and Spot 5 (signal
spots), are bioconjugated to the anti-VEGF capture antibody, Spot 2 and Spot 4 to
the anti-Ang1 capture antibody, whereas Spot 1 to BSA; Spots 1,2,4 are reference
spots.
Fig. 4.10 (a) Photo of the 1DPC surface after the incubation with the spotting tool and before rins-
ing; (b) CCD reflectance map in label-free mode and (c) reflectance profile along the highlighted
measurement line, the image was taken at the start of the experiment in D-PBS; (d) fluorescence
emission recorded by the CCD camera the end of an assay where VEGF was detected; (e) angular
emission profiles of the highlighted regions.
4.2.1 Label-free and fluorescence calibration curves
The label-free measurement recorded the position of the resonance dip to obtain
the label-free signal. After a baseline in D-PBS, 300 µL of the analyte solution
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was injected and recirculated for 10 minutes. The injection and recirculation flow
rate used in all the measurements reported was 30 µl/min. The biochip was then
rinsed with plenty of D-PBS and the label-free detection was completed. The
label-free sensor response was defined as the difference in the resonance dip
position before the sample injection and after rinsing in D-PBS.
Biochips were prepared to detect increasing concentrations of VEGF in D-
PBS in the range 50 to 500 ng/mL. Fig. 4.11(a,b,c) depict the binding of VEGF
monitored in the label-free mode for three different biochips.
Fig. 4.11 Label-free sensorgrams for the detection of VEGF in D-PBS at concentrations of (a) 50,
(b) 125 and (c) 500 ng/mL. Spots 3 and 5 have been functionalized with VEGF specific antibody
while Spots 2, 4 and 1 were reference spots. (d) Resonance position shift plotted against biomarker
concentration shows a good linearity.
The sensorgrams show the angular shift of the resonance for three different
biochips. The residual shifts after the D-PBS washing were averaged in the signal
and reference Spots. The label-free sensor response was then calculated as the
difference between such averaged values. The results reported in Fig. 4.11(d) are
the mean values of duplicate measurements. The label-free response is linear in
the range of VEGF concentrations used in the assays and the sensitivity of the
system was evaluated as SV EGFLF = 0.0286 pixel/[ng/mL]. The standard deviation of
the noise, calculated on a 5 minutes baseline, was σV EGFLF = 0.157 pixel. According
to the IUPAC definition Butler and Laqua (1996), the estimated Limit of detection
(LoD) for label-free operation can be calculated as LoDV EGFLF = 3σ
V EGF
LF / S
V EGF
LF
= 16.5 ng/mL. The estimated LoD is an easy tool to compare the performance
of different sensors. Despite this LoD is in line with optical label-free platforms
that makes use of surface waves, it is still larger than reported plasma VEGF
concentrations in healthy humans and cancer patients, ranging from a few tens
to a few hundreds of pg/ml [Jelkmann (2001),Iinuma (2010),Ławicki et al. (2016)].
However, the platform can efficiently take advantage of the fluorescence mode of
4.2 Comparison between different matrices 67
detection to decrease its LoD and open the way to the detection of lower amount
of biomarkers in complex samples. For this reason it was decided to concentrate
the efforts on the fluorescence detection.
To perform fluorescence detection, in a first phase 300 µL of bioninylated anti-
VEGF-biotin in D-PBS (1 µg/mL) were injected and recirculated for 10 minutes.
After rinsing with D-PBS, any fluorescence background signal was recorded. The
switch between the label-free and fluorescence detection modes was automat-
ically done by the control software when the the cylindrical zoom system was
inserted in the optical path(see Chapter 2). While label-free source was switched
off, fluorescence laser source was started and CCD settings were properly changed.
Then 300 µL of a NeutrAvidin Protein DyLight 650 solution in D-PBS (1 µg/mL)
were injected and recirculated for 10 minutes and finally a wash with D-PBS was
performed before measuring the fluorescence signal. Fig. 4.10(d) displays the
fluorescence detected by the CCD at the end of an assay in which a certain amount
of VEGF was injected. In order to distinguish the Spots, it was possible to refer to
the label-free map, in fact the number and the position of the spots recorded by
the CCD in the fluorescence mode of detection are identical to those defined in
the label-free mode.
A reliable and robust analysis of the fluorescence signal was set up using the com-
plemental label-free signal. For each Spot the angularly dispersed fluorescence
emission was acquired in 50 adjacent CCD camera rows (see the region between
dashed lines in Fig. 4.10(d)). The label-free map was used as a mask to integrate
the intensity of all the lines of a single Spot. First the background fluorescence
was subtracted, then the angular intensity distribution recorded in each CCD
row (Fig. 4.10(e)) was integrated along the angle. Hence, the integral values were
averaged over the 50 rows and to each Spot it was assigned an intensity and its
standard deviation.
The operation in the fluorescence detection mode was calibrated setting the
minimum concentration measured in label-free as the largest. Thus, the spiked
concentrations of VEGF in D-PBS were in the range 2.5-50 ng/mL. Fig. 4.12 reports
the integrated fluorescence intensities of six different experiments, carried out
with different biochips, that constitute one of the duplicate measurement of the
fluorescence calibration. The error bars represent the standard deviation of the
integrated values after the error propagation.
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Fig. 4.12 Fluorescence intensity from VEGF solutions at different concentrations in D-PBS. (a) D
PBS; (b) 2.5, (c) 5, (d) 10, (e) 20, (f) 50 ng/mL. (g) Calibration curve obtained by subtracting the
averaged reference Spots intensity to the averaged signal Spots, each point is the mean value of
duplicate measurements.
Fig 4.12a shows the case in which no VEGF was injected in the biochip (only
the buffer). It appears that the detection antibody is non specifically absorbed
onto the sensor surface and Neutravidin can bind to it resulting in a low non-
specific fluorescence signal. The signal obtained is uniform over the whole surface.
Fig. 4.12(b-f) refer to the case in which solutions containing VEGF were injected,
with increasing concentration. Increasing fluorescence intensities are apparent in
the signal Spots, with a good contrast with respect to the reference ones. For each
VEGF concentration, the final fluorescence intensity is the difference between
the averaged intensities of the Spots 3,5 and the reference. Their variances are
summed in order to obtain the final standard deviations according to the error
propagation theory. The resulting calibration curve is displayed in Fig. 4.12(g)
where each point is the mean value of duplicate measurements. This calibration
has been used to evaluate the unknown VEGF concentration in cell culture super-
natant and spiked plasma samples. The fluorescence intensities obtained can be
fitted with a linear function resulting in a sensitivity of SV EGFF = 460 [a.u.]/[ng/mL].
Making use of the standard deviation of the the blank it is possible to evaluate
the limit of detection for the fluorescence mode of detection LoDV EGFF = 3σ
V EGF
F /
SV EGFF = = 0.98 ng/mL. Such value is one order of magnitude lower than the label-
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free limit and it is closer to the relevant VEGF concentration in human plasma
samples.
4.2.2 Measurement of supernatant samples
Cell culture supernatants were the first step to test the BSW platform with more
complex matrices. Cell supernatants collected from wild-type and VEGF165-
overexpressing Colo205 and MCF-7 cells were used. The concentrations of VEGF in
cell supernatants were first assessed via ELISA. Wild-type Colo205 and MCF-7 cells
expressed a VEGF basal level smaller than 1 ng/mL, while VEGF165-overexpressing
cells released an increased amount in the supernatant, i.e. 16.9 ng/mL. The mea-
sured concentrations are reported in Table 4.1.
Table 4.1 Results of ELISA tests for the assessment of biomarkers concentration in cell culture
supernatants. Values are the mean ±SD of 3 experiments.
Cell type VEGF amount [ng/mL]
MCF-7WT 0.770±0.005
MCF-7 VEGF165 15.539±0.195
Colo205 WT 0.647±0.232
Colo205 VEGF165 16.944±0.111
The VEGF concentration was measured in undiluted and diluted cell super-
natants in D-PBS (Fig. 4.13). In particular, MCF-7 VEGF165 sample was diluted
by a ratio of 1:4 while Colo205 VEGF165 sample by a ratio of 1:2. From the dif-
ferential fluorescence intensities evaluated from Fig. 4.13(a-b) and making use
of the fluorescence calibration curve shown in Fig. 4.12(g), it was possible to re-
trieve the following estimation of the VEGF concentration: 14 ng/mL and 4 ng/mL
for the undiluted and 1:4 diluted MCF-7 VEGF165 samples, respectively and 21.5
ng/mL and 8.5 ng/mL for the undiluted and 1:2 diluted Colo205 VEGF165 sample.
In Fig. 4.13(c) are plotted the fluorescence calibration curve together with data
points corresponding to the intensities for the cell culture supernatant samples.
These values show a good agreement between the BSW platform and results ob-
tained via ELISA. Furthermore, the intensities obtained from the diluted samples
are consistent with the undiluted ones. The reported results demonstrate that the
biosensing platform can successfully perform biomarker detection in cells culture
supernatants.
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Fig. 4.13 Fluorescence intensities from cell culture supernatant samples: (a) undiluted Colo205
VEGF165 sample containing VEGF at 17 ng/mL; (b) 1:2 diluted Colo205 VEGF165 sample; (c)
undiluted MCF-7 VEGF165 sample containing VEGF at 15.5 ng/mL; (d) 1:4 diluted MCF-7 VEGF165
sample. (f) Calibration curve (Fig. 4.12) and cell culture supernatant results.
4.2.3 Measurement of spiked blood samples
Human plasma samples were collected from a pool of apparently healthy patients.
The total amount of sample used for one measurement is 300 µl. The concentra-
tions of VEGF in the human plasma samples were assessed also via ELISA and
revealed a concentration of VEGF lower than 0.3 ng/mL.
Due to the extremely low concentration of VEGF a certain amount of the re-
combinant VEGF protein was added in two plasma samples. The amount added
was enough to obtain two samples at concentration 3.75 and 15 ng/mL. The re-
sults are shown in Fig. 4.14. The fluorescence signals in the Spots 3,5 could be
distinguished from those in the reference Spots and the fluorescence intensities
returned, through the calibration curve, VEGF concentrations of 3.5 and 14 ng/mL,
for the two samples. Such values are in good agreement with the spiked concen-
trations. It is worth to mention that protein fouling, the unspecific adsorption
on the sensor surface due to complex biological matrices, was not a problem for
the fluorescence operation mode, both in supernatants samples and in plasma
samples from different donors. The results presented in Fig. 4.13 and Fig. 4.14
show that the BSW platform, together with the strategy adopted to calculate the
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Fig. 4.14 (a) Fluorescence measurements of plasma sample with a spiked VEGF concentration of
3.75 ng/mL and (b) plasma sample with 15 ng/mL spiked concentration of VEGF. (c) Calibration
curve (Fig. 4.12(g)) and spiked plasma samples results.
fluorescence intensity, allow to measure different biomarker concentrations in
different complex matrices.
4.3 Determination of Angiopoietin-2 in human plasma
samples
Angiogenesis, the formation of new blood vessels from pre-existing ones, is one of
the most intensively studied areas of cancer research in recent years. Although in
adulthood angiogenesis is generally required to repair tissue and remodel tissues
involved in menstruations, cancers can use angiogenesis to allow their growth and
metastasis [Maisonpierre et al. (1997)]. Indeed, after reaching a diffusion-limited
size, many tumors rely on an angiogenic switch, rendering tumor angiogenesis
one of the hallmarks of cancer. In basic research, traditional (largely qualita-
tive) biochemical, biomolecular and microscopy-based techniques had provided
fundamental information with regard to the main mechanisms involved in tu-
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mor angiogenesis. The release of angiogenic factors by tumor cells establishes
a dynamic tumor microenvironment where intricate intracellular paths lead to
the phenotypic changes required to sustain tumor growth. Angiopoietin ligands
belong to a novel class of angiogenic factors that, together with Tie receptors,
play a critical role in blood and lymphatic vessel development, inflammation
and tumor vascularization [Eklund and Saharinen (2013)]. Among angiopoietin
molecules, Angiopoietin-2 (Ang2) has been widely investigated due to its function
in the inhibition of the tumor vasculature and in other pathological conditions
associated with endothelial dysfunction [Eklund and Saharinen (2013),Loughna
and Sato (2001)]. Quantitative detection of angiogenic biomarkers such Ang2 can
be a powerful tool to diagnose cancers in early stages and to follow its progression
during therapy [Pepe et al. (2001)]. Moreover, Ang2 plasma level has been found
to be correlated with cerebral cavernous malformation [Zhao et al. (2016)] and
disease severity in human cancers [Park (2007)]. It may also assist in the diagnosis
of difficult lesions [Teixeira et al. (2016)]. Monitor Ang2, as well as other angiogenic
factors, is therefore desirable for future development of targeted anti-angiogenesis
therapy in cancer and/or in other diseases.
Here it is presented the enhanced fluorescence detection of Ang2 biomarker
directly from human plasma. This was the first biosensor assay that used BSW
for the detection of Ang2 from patients’ plasma samples at clinically relevant
concentrations.
Biochips were functionalized and measured according to the procedures de-
scribed in the previous sections. Also in these experiments a sandwich immunoas-
say format with antibodies against Ang2 immobilized on the 1DPC surface was
chosen. The five channel functionalization flow cell was used to immobilize the
specific anti-Ang2 capture antibody as well as BSA molecules and a non-specific
capture antibody, precisely the antibody specific for VEGF. Two channels were
used to incubate 20 µg/mL of the anti-Ang2 capture antibody, other two channels
were filled with 20 µg/mL of the anti-VEGF and one was dedicated to BSA, 10
mg/mL. The volume used was 20 µL for each channel. The sandwich immunoas-
say adopted is sketched in Fig. 4.15 as a reminder.
Analyzed liquid samples were flowed over the functionalized biochip (Fig. 4.15(a))
and Ang2 molecules bond to the surface (Fig. 4.15(b)). In order to detect a fluores-
cence signal a biotinylated detection antibody solution (1 µg/mL in D-PBS) was
injected in the microfluidic channel. At this point the fluorescence background
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Fig. 4.15 Sandwich assay for the detection of Ang2 biomarker. Refer to text for details.
was recorded. The detection antibody was in turn labelled with an appropriate
fluorophore (NeutrAvidin Protein DyLight 650, 1 µg/mL in D-PBS, Fig. 4.15(c)).
Fluorescence detection (Fig. 4.15(d)) was performed after a final wash of the mi-
crofluidic channel. The volume of all solutions used, from the analyte solution that
contained the target biomarker to the one in which the labelling dye was present,
was 300 µL and all the solutions were recirculated for 10 minutes. Between each
step the microfluidic channel was rinsed with abundant D-PBS increasing the
flow rate to 50 µL/min.
Fig. 4.16(a) displays the arrangement of the bio-conjugated regions together
with the fluorescence intensity of detected by the CCD at the end of an experiment
in which a certain amount of Ang2 was injected (Fig. 4.10(b)). A clear fluorescence
signal arose from regions that were bio-conjugated to anti-Ang2, while poor signal
strength was observed from the reference regions.
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Fig. 4.16 (a) Sketch of a functionalized biochip after the incubation with the spotting tool; (b)
fluorescence emission recorded by the CCD camera the end of an assay where Ang2 was detected;
(c) angular emission profiles of the highlighted regions.
4.3.1 Fluorescence characterization and immunoassay limit of
detection
Ang2 levels in patients with cancer are generally higher than 1 ng/mL [Caine et al.
(2003),Engin et al. (2012a),Engin et al. (2012b)]. In order to use the BSW biosensing
system to quantify Ang2 levels in patients’ plasma it needs to be calibrated. To
this purpose, duplicate standards of Ang2 in the range 2.5 to 50 ng/mL were
prepared in D-PBS by serial dilution of a stock solution of 1 mg/mL of Ang2
in D-PBS. Calibration curves were obtained employing concentrations of 2.5,
5, 10, 20 and 50 ng/mL. Pure D-PBS was used as negative sample. Fig. 4.17(a)
shows the fluorescence intensities recorded by the CCD for the calibration curve
concentrations. In case only D-PBS was injected during the measurement, the
platform detected a very low uniform signal from the whole surface. However,
when a solution which contains Ang2 was injected, the produced signal by the
anti-Ang2 regions could be distinguished with a good contrast.
Fig. 4.17(b) reports the integrated fluorescence signal of analogues regions.
The bar plot shows increasing signal in response to increasing Ang2 concentra-
tions. Standard deviations of the mean values were calculated as the sum of the
variances associated to the signal emitted from each region according to the error
propagation theory. It is worth to mention that such standard deviations spread
with increasing concentration of Ang2 but relative values are constant.
On chip reference regions have been introduced purposely to take into account
any effect that may alter the detected signal, i.e. non-specific absorption of any
molecule. The overall response of the system was assessed as the difference be-
tween the averaged intensities of the regions bio-conjugated with anti-Ang2 and
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Fig. 4.17 Fluorescence intensities from Ang2 solutions at different concentrations in D-PBS.
(a) Fluorescence intensities recorded by the CCD at the end of the assay. Each concentration
correspond to a single assay conducted on a single biochip. (b) Integrated and averaged intensities
for related regions of the functionalized biochips, error bars represent the standard deviation
associated to the integrated and averaged values.
the reference regions.
The averaged responses of the two standards measured for each concentration are
plotted versus the Ang2 concentration in Fig. 4.18 and fitted to a four-parameter
Boltzmann equation:
y = A1− A2
1+e(x−x0)/A3 + A2.
where y is the measured fluorescence intensity, x is the Ang2 concentration,
A1 and A2 are the asymptotic minimum and maximum respectively. the slope in
x=x0 is S
Ang 2
F =(A2- A1)/4A3. The function was chosen to take into account that
the enhanced fluorescence signal produced by the 50 ng/mL solution almost
saturated the CCD detector. All the measurements have been conducted with
the same exposure time but in case of need this setting can be reduced and the
biosensing system can explore higher ranges of concentration.
The slope SAng 2F in the linear region the sensitivity of the BSW platform for
this bioassay. The LoD can be evaluated making use of the standard deviation of
the blank through the formula LoDAng 2F = 3σ/S
Ang 2
F ∼1.5 ng/mL. This calculated
LoD is compatible with the concentration ranges of Ang2 in plasma from patients
with metastatic colorectal cancer [Caine et al. (2003),Engin et al. (2012a),Engin
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Fig. 4.18 Calibration curve of Ang2 in D-PBS. Each point represents the mean value of two
replicate measurements.
et al. (2012b)]. The obtained calibration curve has been used to evaluate the Ang2
concentration in patient plasma samples.
4.3.2 Detection of Ang2 in human plasma samples
Collection, processing, storage and use of human blood samples strictly adhered
to the protocol approved by the Institute’s Ethical Commission and the Ethical
Committee Piedmont Region, Torino (Italy). Patient’s identifiers are kept to a
minimum, i.e., the normal personal identifiers were replaced by an artificially-
created identifier that here are reported as “Plasma sample” 1/2/3. For each
patient, after obtaining informed consent, blood sampling was done in order
to obtain plasma samples before a therapy cycle, during the therapy, and after
the therapy. After having informed the patient, during a routine blood sampling
for diagnostic purpose an additional blood volume (∼12 mL) was collected. The
additional blood volume was collected in different test tubes to allow plasma
preparation. Plasma were prepared according to the procedure described in
previous sections. Considering the same biological sample, some aliquots of
plasma were assayed for the quantification of Ang2 by ELISA, while others were
devoted to the measurement via the BSW system. Three different samples were
measured. Two plasma samples, i.e. plasma sample 1 and 2, were collected
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from the same patient but in different moment of the tumor progression. ELISA
determination revealed that the Ang2 concentration was around 6 ng/mL in all
the three samples. Samples’ aliquots were then measured with the developed BSW
system and the results are reported in Table 4.2. These data reveal good agreement
between both methods with percentage deviation from ELISA results less than
10%. Duplicate measurements of each sample were considered.
Table 4.2 Detected Ang2 in plasma samples from metastatic colorectal cancer patients by BSW
system in comparison to ELISA. For the BSW system, each calculated value represent the mean of
duplicate measurements.
Detected Ang2 concentrations [ng/mL]
BSW platform (σ) ELISA
Plasma sample 1 6.2 (0.4) 6.7
Plasma sample 2 5.8 (0.4) 5.7
Plasma sample 3 5.3 (0.2) 5.8
The bioassay accuracy can be assessed by evaluating the results variability
for the same plasma sample. The concentrations obtained are the mean value of
duplicate measurements done in different days every time with a pristine sample.
The coefficients of variation for plasma sample measurements are reported in
Table 4.3. The table present also the variability of the calibration procedure. As
already mentioned, duplicate standard curves were prepared and each concen-
tration, i.e. 2.5, 5, 10, 20, 50 ng/mL, was tested on a single biochip. Mean values
of the coefficient of variations are below 6% for both plasma measurements and
standards. Moreover, all the individual values are below 10%. These coefficients
are acceptable variability values for analytical methods.
Table 4.3 Assay variations in plasma samples measurements and in the calibration procedure.
Sample 1 Sample 2 Sample 3 Mean
Coefficient of variation of
measured plasma samples 6.68 7.23 3.18 5.70
Calibration curve points [ng/mL]
2.5 5 10 20 50
Coefficient of variation of
standards 5.9 5.53 7.62 5.14 5.34 5.78
"
Chapter 5
More compact readout scheme:
gratings and BSW
" Among the optical readout schemes, fluorescence has become the dominant
detection/sensing technology in medical diagnostics and biotechnology [Taitt
et al. (2016),Lakowicz (2006)]. The microarray approach provides a simultane-
ous analysis of thousands of parameters within a single experiment, resulting
in rapid response time analysis. In the attempt to provide a more compact and
miniaturized chip for an enhanced fluorescence biosensing, in this chapter a
nanopatterned 1DPC structure is proposed. This section was published in Riccia-
rdi et al. (2015).
5.1 Nanopatterned 1DPC
The nanopatterned 1DPC is integrated on a PDMS lab on a chip for a miniaturized
fluorescence assay. The optofluidic chip is made of a photonic substrate consti-
tuted by amorphous materials deposited on glass and a PDMS fluidic membrane
for solution/analyte handling (sketch in Fig. 5.1).
The photonic structure is based on a 1DPC that is surface-patterned as an
array of linear subwavelength corrugations. The use of such a photonic substrate
allows an enhancement and a beaming of the emitted radiation towards the
observer, in such a way that the fluorescence collection is largely improved even
with low-cost optics. The overall system can be optically interrogated by means of
an extended excitation laser beam. The resulting fluorescence can be collected
through a collection optics arranged in a simple wide-field configuration, with no
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Fig. 5.1 Schematic (a) sketch of the optofluidic chip. A 1DPC is patterned with 4 groups of
linear subwavelength gratings and bond to a PDMS microfluidic membrane whose 4 independent
cells (provided with independent inlet and drain channels) are respectively aligned to each of the
grating groups; (b) optical image of 1 grating group constituted by 6 gratings; (c) SEM image of a
detailed portion of a linear grating.
need of any scanning mechanism. Thanks to the high transparency and optical
quality of the PDMS cover, the optical excitation/detection can be implemented
from either the PDMS or the glass substrate side [Choi and Cunningham (2006)].
The 1DPC is constituted by 20 alternating layers of Ta2O5 and SiO2, deposited
on a thin glass substrate by PIAD. The Ta2O5 and SiO2 layers are 95 and 137 nm
thick respectively, while the top SiO2 layer is only 127 nm thick. On top of the
stack a pattern of linear gratings with a period of Λ = 530 nm is fabricated by
electron beam lithography, followed by a sputter deposition of SiO2 (K. J. Lesker
PVD 75 DC Magnetron Sputtering). Gratings are arranged into four groups, each
group including six grating pads, 250 µm × 250 µm in size. Grating groups are
respectively separated by 4 mm, in such a way that each group can observed with
a single micro-fluidic cell, with independent inlet and outlet. The resulting grating
height is about 100 nm. In order to provide a practical implementation of the
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BSW-assisted fluorescence detection, the photonic structure is integrated onto
a PDMS microfluidics and a biosensing protocol as follows is performed. The
immunological assay consists of the specific recognition of Actin and Anti-Actin
antibody molecules. Antibody species are immobilized on the solid support, upon
proper chemical modification. Fluorescently labelled Actin molecules(Actin-Alexa
Fluor 568) are employed as target molecules. The specific binding of Antibodies
on the 1DPC surface is promoted by a functionalization procedure based on
APTES (ref Chapter 3). After the surface functionalization, the photonic structure
can be bonded to the PDMS microfluidics. Antibody solutions (50 µg/ml) are
incubated all over the surface. As a result, the biomolecules are covalently grafted
[Fiorilli et al. (2008)] both on the linear gratings and outside them, on the flat 1DPC
surface. After incubation, samples are deeply rinsed in PBS-Tween 20 (0.05%)
and in deionised water, to remove non-specific signal derived from molecules
not covalently grafted on the surface; then samples are dried under nitrogen
flux.After antibodies immobilization, Actin-Alexa Fluor 568 solutions at different
concentrations are incubated corresponding to the four different grating groups
(covering areas inside and outside the gratings). Then, a rinsing step in PBS-Tween
20 (0.05%) and in deionised water is performed. Finally, a nitrogen stream is used
for drying.The detection is performed by means of a simplified fluorescence
microscope, as illustrated in Fig. 5.2.
Briefly, fluorescence is excited with a doubled frequency Nd:YAG laser beam
(wavelength λ = 532 nm) that is firstly focused from a single-mode fibre and then
collimated onto the sample through a NA = 0.1 objective. The laser spot can
homogeneously illuminate a single grating pad. Illumination is incident from the
glass substrate (bottom side) and polarized parallel to the grating groves. This
arrangement allows for the resonant excitation of BSW by means of the laser,
providing an additional mechanism for fluorescence enhancement. On the air-
side, the fluorescence emitted in the free-space and the transmitted laser light
can prop-agate through the transparent low-roughness PDMS membrane and
collected by a NA = 0.2 objective. After laser filtering, a fluorescent image of the
photonic crystal surface is obtained. Thanks to the BSW-assisted beaming effect
described above, the corrugated areas show a brighter fluorescence intensity that
can be directly compared to the flat 1DPC regions imaged within the collection
objective field of view. It should be noted, however, that lower NA optics can
be used in alternative, since the BSW-assisted fluorescence beaming shows a
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Fig. 5.2 Sketch of the optical setup for microarray fluorescence imaging. Also shown, exemplary
pictures of the optofluidic chip hosting 4 groups of linear gratings and the PDMS microfluidics.
divergence well below an angular spread of 10 deg. The analyzer in the collection
path is not used here.
5.2 Computational model
The one dimensional photonic crystal (1DPC) has been designed in such a way
that TE-polarized BSW are allowed to propagate at their truncation surface. In
this case, BSW are sustained for wavelengths shorter than 620 nm. In previous
chapters, the angular emission distribution have been demonstrated to change
significantly for fluorophores located in close proximity to the 1DPC surface. As
already stated, a light source oriented with its dipole momentum parallel to the
1DPC flat surface (as sketched in Fig. 5.3(a)) can couple a significant portion of
the emitted power into the BSW sustained by the 1DPC itself. This BSW-coupled
fluorescence propagates as a surface wave on the 1DPC surface, as illustrated by
the Finite Element Method (FEM) calculations shown in Fig. 5.3(b). During the
surface-propagation, the BSW-coupled fluorescence leaks into the glass substrate,
where it radiates as a free-space wave along a specific direction determined by the
BSW wavevector. The readout scheme used in the previous chapters exploited a
prism configuration to detect the BSW-coupled fluorescence. In alternative, if the
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1DPC is patterned with a linear corrugation having a suitable period (Fig. 5.3(c))
and the emitter is still located close to the surface, the BSW-coupled fluorescence
propagating parallel to the grating direction is directly diffracted and shot out
in the free space [Angelini et al. (2014a)]. This mechanism is illustrated by the
FEM calculations presented in Fig. 5.3(d and e), wherein a high-intensity beam of
light emitted normally to the 1DPC surface is observed. The advantage of using a
suitable diffraction grating on top of the 1DPC can be better appreciated when the
angular distribution of the integral power emitted by the source on the photonic
structure is considered (Fig. 5.3(f)).
Fig. 5.3 Cross sectional sketch of flat (a) and patterned (c) multilayer; calculated near-field
intensity distribution of light radiated by an emitter close to the surface of a flat (b) and patterned
(d) multilayer; (e) expanded view of the intensity distribution of BSW-coupled diffracted fluores-
cence; (f) angular pattern of emitted light in the case of flat and corrugated 1DPC, highlighting the
BSW-assisted beaming.
The linear grating out-couples the BSW-coupled fluorescence that would be
otherwise leaking into the glass substrate (blue line) and barely detected without
using a prism or an immersion optics. As a result, a spectacular beaming effect (red
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line) is produced, shooting the emitted fluorescence normally to the 1DPC surface
with a very low angular divergence. Due to the linear geometry of the grating, this
beaming effect occurs substantially on a plane containing the grating vector.In this
way, a very low numerical aperture (NA) collection optics can indeed be used to
efficiently collect a large amount of emitted fluorescence, therefore improving the
performance of a low-cost fluorescence assay. The use of transparent, dielectric
materials allows an easy design of photonic structures exhibiting (diffracted) BSW
tuned at the desired emission wavelengths of operation [Angelini et al. (2014b)].
In the calculations presented in Fig. 5.3, the emitter radiates at a wavelength λ =
580 nm, thus demonstrating the capability of the proposed photonic structure to
operate in the visible spectral range.
5.3 Fluorescence detection
When the fluorescence-labelled biomolecules are grafted on the photonic surface
of the optofluidic chip, it is possible to produce a fluorescence image of each single
grating by adjusting the magnification of the detection unit previously shown.
In alternative, an imaging setup may be provided, allowing a wider field-of-view
containing multiple gratings that can be collectively illuminated.In the present
case, the laser homogeneously illuminates a single grating pad. The signal en-
hancement on the grating can be appreciated from Fig. 5.4(a), wherein exemplary
fluorescence images of the photonic crystal surface are considered. The illumi-
nation spot (yellow dashed circle) is slightly offset with respect to the grating, in
such a way that the fluorescence intensity discontinuity at the grating edge can be
clearly observed. Then, a cross-sectional intensity profile across the illuminated
area can be taken corresponding to the grating. This intensity distribution is
directly compared and superposed to the fluorescence profile of the illumination
area without grating (Fig. 5.4(b)). The illumination power being the same,the
on-grating fluorescence shows an intensity enhanced approximately by a factor of
20. A titration curve can be built, by using different concentrations of Actin-Alexa
Fluor solutions as target (0.042 µg/ml,0.084 µg/ml, 0.168 µg/ml, 0.420 µg/ml,
0.840 µg/ml, 1.680 µg/ml,4.2µg/ml, 8.4 µg/ml, 16.8 µg/ml, 42 µg/ml, 84 µg/ml,
168 µg/ml) in D-PBS prepared by serial dilution. Till to four different solutions
of Actin-Alexa Fluor are simultaneously incubated on the four different gratings
groups, each one provided with a dedicated microfluidic chamber. Fluorescence
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intensities are collected from the gratings and from the flat regions beside the
gratings and plotted as shown in Fig. 5.4(c).For each Actin concentration, the
quantification of the fluorescence intensity has been performed by calculating an
average intensity over the illuminated areas either on gratings or on flat regions.
The error bars take into account the intensity variation within each spot and
over the 6 gratings incubated at identical concentration. Collected data are well
fitted by sigmoidal profiles, as expected. At low concentrations, the fluorescence
intensity is dominated by the background, thus preventing small changes in the
amount of Actin molecules grafted on the surface to be resolved. The background
is estimated by collecting the fluorescence from the photonic crystal surface with
no Actin-Alexa Fluor molecules incubated on it. However, as the photonic en-
hancement mechanism occurs also for the background fluorescence, two different
background levels have to be considered separately for grating and flat regions.
More particularly, the background level on the grating is higher (see Fig. 5.4(c)).
At increasing concentrations, the fluorescence collected on the gratings is
significantly enhanced as compared to the flat areas. This signal enhancement
leads to an overall decrease of the limit of detection (LoD) for Actin concentration
by a factor of about 40, as illustrated in the figure. For the LoD determination,
the mean background level (with only APTES on the surface) increased by 3σ
as a threshold was considered, where σ represents the standard deviation of the
background fluorescence. As a result, in this assays, Actin down to 0.168 µg/ml
concentration can be clearly detected on the gratings, whist on flat areas it is not
possible to discriminate from the background Actin concentrations lower than 8.4
µg/ml.
"
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Fig. 5.4 (a) Fluorescence image of the photonic crystal surface (grating and flat area), illuminated
by a collimated laser beam. The illumination beam is indicated by the dashed yellow circle
and is slightly offset with respect to the grating position; (b) cross sectional intensity profiles of
fluorescence across the grating (blue solid line) and across the flat area (red solid line), illuminated
by the same laser beam intensity. An increase by approximately a factor of 20 is observed in the
collected fluorescence corresponding to the grating, as compared to the outside; (c) titration
curve of fluorescence collected for different labelled Actin-Alexa concentrations, grafted to Anti-
Actin receptors. The increase of the fluorescence intensity shifts down the minimum observable
Actin-Alexa concentration by a factor of 40 approximately.
Chapter 6
Conclusions
" In this thesis manuscript, I have shown many of the aspects related to BSW
biosensing on one dimensional photonic crystals, from the design and optimiza-
tion of the 1DPC till the measurements of real human plasma samples and the
development of a more compact readout scheme for the fluorescence enhance-
ment.
As seen in Chapter 1, modelling an angular resonance as a simple quadratic
function provides a numerical estimation of the noise of resonance position deter-
mination. In the limit of wide resonance widths the results compare to previous
findings. Noise of minimum position determination has been converted into a
limit of detection as an assessment criterion of the sensor device which takes
into account the angular range that has to be detected by the optical system.
Compared to the well established figure of merit, which relates sensitivity, reso-
nance depth and resonance width for narrow angular range detecting systems,
the additional involvement of the angular range introduces considerations of free
measurement range and tolerances. The limiting case of very narrow resonances
has been modelled analytically by discretization errors that can be related to
mechanical stability issues of the system. Furthermore, a variety of stacks with
regard to the number of periods and the layer thicknesses exhibit high sensitivity
values that yield a linear relation between high and low index layer thicknesses,
respectively. Then, the number of periods and layer thickness needs to be fixed for
adjusting resonance depth D and angular range A in order to obtain a minimum
limit of detection LoD.
In Chapter 2 fabrication of 1DPC was investigated. a-SiNx:H and a-SiOxCy:H
thin films have been deposited by means of PECVD. The refractive index disper-
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sion of selected binary and ternary alloys has been extracted in order to design
periodic multilayers that have been optimized for the coupling of BSW. Although
the designed silicon-based multilayers could be exploited for sensing experiments,
only the 1DPC coated with the PIAD method were used in the subsequent mea-
surement mainly due to the high number of substrates that can be coated in a
single deposition run. Morover, the analysis of the angular resolved reflectance
of PIAD multilayers which feature BSW resonances allowed the determination of
low intrinsic losses down to 10−6 ∼ 10−5. The losses measured for the BSW-stacks
are seemingly reliable. The findings about n and k values of the deposited PIAD
materials were used to design the final BSW multilayer that have been used to
perform the bioassays. The optical system exploited for the measurements was
also disclosed. The BSW platform takes advantage of a tandem configuration
label-free/fluorescence and is furnished with a plastic disposable and low cost
sensor unit.
Chapter 3 reports the surface functionalization technique that have been
used for the measurements. The 1DPC surface was made bio-compatible through
APTES chemistry and GAH crosslinker. Specific antibodies for the targeted biomark-
ers were bio-conjugated to the sensitive area of the sensor by means of a microflu-
idic spotting tool.
Finally in Chapter 4 the biosensing experiments are shown. Using a novel
biosensing BSW platform it was demonstrated the detection of the VEGF cancer
biomarker in matrices of increasing complexity, such as cell culture supernatants
and human plasma samples. The label-free technique has a great LoDV EGFLF of 16.5
ng/mL, can provide useful information about the kinetics of the binding reactions
and the lowest concentration detected was 25 ng/mL. The fluorescence detection
mode could detect VEGF molecules down to 2.5 ng/mL in human plasma samples
with a calculated LoDV EGFF of 0.98 ng/mL, close to the plasma VEGF concentration
values previously reported for cancer patients (i.e., in the order of one hundred or
a few hundreds of pg/ml).
The proposed biosensing system demonstrated also its usefulness for the detec-
tion of relevant clinical levels of the angiogenic factor Ang2 in patient plasma
samples. The platform LoD has been found compatible with clinically relevant
concentrations inside patients plasma samples. The system was capable to de-
terminate Ang2 concentration in plasma samples using low volumes, 300µl, with
short turnaround times ,30 minutes, and without any sample pre-treatment or di-
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lution. This was the first BSW based biosensor assay for the determination of Ang2
in plasma samples at relevant concentrations. The robustness was assessed with
the good reproducibility proven by low coefficients of variation. The fluorescence
outcome was comparable between more than 15 measurements in different days.
The Ang2 plasma concentrations determined with the BSW system were validated
by ELISA measurements and a good agreement between both results were found.
An optofluidic chip made of a nanopatterned 1DPC integrated on a elas-
tomeric microfluidics has been proposed for fluorescence-based sensing in Chap-
ter 5. Thanks to the radiation beaming provided by the photonic structure, a
high-efficiency fluorescence collection can be obtained even with low NA optics.
An overall improvement in detecting antigene molecules has been demonstrated
with a simple home-made fluorescence imaging setup. The approach can be
advantageously exploited in compact, low-cost optical systems for the fluores-
cence read-out of miniaturized optofluidic chips in point-of-care devices. For
a reproducible and robust spotting of labelled analytes, a flow-through PDMS
membrane aligned to the grating areas can be employed.
The outcomes of this thesis affirm that the BSW biosensing platforms can be
a valuable tool for fast diagnostics of different type of biomarkers and paves the
way for the development of multiplexing BSW biosensor for the detection and
monitoring of multiple clinical analytes.
"
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